α-ET
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
α-MT†
US: CSA Schedule I Section d Subsection 16 Alpha-methyltryptamine
α-PBP
US: CSA Schedule I Section h Subsection 20 alpha-Pyrrolidinobutiophenone
α-PVP
US: CSA Schedule I Section h Subsection 13 alpha-Pyrrolidinopentiophenone
⇒
PubChem: 11148955; ChemSpider: 9324063; Drugs Forum: ?-PVP; Wikipedia: alpha-Pyrrolidinopentiophenone
1,4-BD†
CA: CDSA Schedule VI Part 1 Subsection 19 1,4-Butanediol
UK: MDA Part III Class C Section 1(b) 1,4-Butanediol
⇒
PubChem: 8064; ChemSpider: 13835209; Drugs Forum: 1,4-Butanediol; Erowid: 1,4-Butanediol; Wikipedia: 1,4-Butanediol
25B-NBOMe†
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
25C-NBOMe†
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2,5-DMA
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
25D-NBOMe†
UK: MDA Part I Class A Section 1(f) 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
25I-NBOMe†
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2 C-B
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
2C-B
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
2C-B-NBOMe
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2C-C
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 40 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
2C-C-NBOMe
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2C-D
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-methylphenethylamine
US: CSA Schedule I Section d Subsection 39 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
2C-E
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 38 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
2C-G-3†
UK: MDA Part I Class A Section 1(ba) 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
2C-G-4†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2C-G-5†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2C-G-N†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2C-H
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 44 2-(2,5-Dimethoxyphenyl)ethanamine
2C-I
EU: Substances Substances 2C-I
UK: MDA Part I Class A Section 1(c) 4-Iodo-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 41 2-(4-Iodo-2,5-dimethoxy-phenyl)ethanamine
2C-I-NBOMe
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2C-N
US: CSA Schedule I Section d Subsection 45 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
2C-P
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-propylphenethylamine
US: CSA Schedule I Section d Subsection 46 2-(2,5-Dimethoxy-4-(n)-propyl-phenyl)ethanamine
2C-T-2
EU: Substances Substances 2C-T-2
UK: MDA Part I Class A Section 1(c) 4-Ethylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 42 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
2C-T-4
UK: MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine and 4-Isopropylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 43 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
2C-T-7
EU: Substances Substances 2C-T-7
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
US: CSA Schedule I Section d Subsection 6 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
3-FMC
US: CSA Schedule I Section h Subsection 18 3-Fluoro-N-methylcathinone
4-FMC
UK: MDA Part II Class B Section 1(aa) Flephedrone
US: CSA Schedule I Section h Subsection 17 4-Fluoro-N-methylcathinone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone
4-H2PO4-DMT†
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
4-HO-DMT†
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
4-MA†
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
4-MEC
US: CSA Schedule I Section h Subsection 11 4-Methyl-N-ethylcathinone
⇒
PubChem: 52988259; ChemSpider: 25630091; Drugs Forum: (4-MEC); Erowid: 4-Methylethcathinone (4-MEC); Wikipedia: 4-Methylethcathinone
4-MePPP
US: CSA Schedule I Section h Subsection 12 4-Methyl-alpha-pyrrolidinopropiophenone
4-MTA
UK: MDA Part I Class A Section 1(ba) α-Methyl-4-(methylthio)phenethylamine
UN: Psychotropics Schedule I 4-MTA
5-APB†
UK: MDA Part II Class B Section 1(e) 1-(Benzofuran-5-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(Benzofuran-5-yl)-propan-2-amine
5-APDB†
UK: MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
5-API†
EU: Substances Substances 5-(2-Aminopropyl)indole
UK: MDA Part II Class B Section 1(e) 1-(1H-Indol-5-yl)-1-methylethylamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(1H-Indol-5-yl)-1-methylethylamine
⇒
PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
5F-AKB48
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
5F-PB-22
CA: CDSA Schedule II Section 2 Subsection 7 1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 8 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
5F-UR-144
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
5-HO-DMT†
UK: MDA Part I Class A Section 1(a) Bufotenine
US: CSA Schedule I Section d Subsection 17 Bufotenine
5-IT†
EU: Substances Substances 5-(2-Aminopropyl)indole
UK: MDA Part II Class B Section 1(e) 1-(1H-Indol-5-yl)-1-methylethylamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(1H-Indol-5-yl)-1-methylethylamine
⇒
PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
5-MeO-DMT†
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-dimethyltryptamine
US: CSA Schedule I Section d Subsection 15 5-Methoxy-N,N-dimethyltryptamine
6-APB†
UK: MDA Part II Class B Section 1(e) 1-(Benzofuran-6-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(Benzofuran-6-yl)-propan-2-amine
6-APDB†
UK: MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
6-IT†
UK: MDA Part II Class B Section 1(e) 1-(1H-Indol-6-yl)-1-methylethylamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(1H-Indol-6-yl)-1-methylethylamine
AB-FUBINACA†
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 9 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
AB-PINACA†
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 22 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
Acetic anhydride
CA: CDSA Schedule VI Part 1 Subsection 1 Acetic anhydride
EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
UK: MDA Drug precursors Annex I Category 2 Acetic anhydride and Drug precursors Annex II Acetic anhydride
UN: Precursors Table I Acetic anhydride
US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
Acetic oxide
CA: CDSA Schedule VI Part 1 Subsection 1 Acetic anhydride
EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
UK: MDA Drug precursors Annex I Category 2 Acetic anhydride and Drug precursors Annex II Acetic anhydride
UN: Precursors Table I Acetic anhydride
US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
Acetorphine
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UK: MDA Part I Class A Section 1(a) Acetorphine
UN: Narcotics Part 1 Section 1 Acetorphine and Section 3 Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
Acetyl fentanyl
US: CSA Schedule I Section h Subsection 24 N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide
Acetyl-alpha-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
N-Acetylanthranilic acid
CA: CDSA Schedule VI Part 1 Subsection 2 N-Acetylanthranilic acid
EU: Drug precursors Annex I Category 1 N-Acetylanthranilic acid
UK: MDA Drug precursors Annex I Category 1 N-Acetylanthranilic acid
UN: Precursors Table I N-Acetylanthranilic acid
US: CSA Listed Chemicals Section a Subsection 6 N-Acetylanthranilic acid
![3D rendering of (6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide](data:image/png;base64,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 "Click for a 3D rendering of (6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide")
(6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
UK: MDA Part I Class A Section 1(a) (6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Acetyldihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 6 Acetyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Acetyldihydrocodeine
UN: Narcotics Part 1 Section 2 Acetyldihydrocodeine and Part 2 Section 1 Acetyldihydrocodeine
US: CSA Schedule I Section c Subsection 2 Acetyldihydrocodeine
Acetyletorphine
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UK: MDA Part I Class A Section 1(a) Acetorphine
UN: Narcotics Part 1 Section 1 Acetorphine and Section 3 Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
Acetylmethadol
CA: CDSA Schedule I Section 6 Subsection 1 Acetylmethadol
UK: MDA Part I Class A Section 1(a) Methadyl acetate
UN: Narcotics Part 1 Section 1 Acetylmethadol
US: CSA Schedule I Section b Subsection 2 Acetylmethadol
Acetyl-α-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
Acetyl-alpha-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
N-(Adamantan-1-yl)-1-fluoropentylindole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 9 N-(Adamantan-1-yl)-1-fluoropentylindole-3-carboxamide
⇒
PubChem: 57404059; ChemSpider: 28189067; Bluelight: STS-135; Drugs Forum: STS-135; Wikipedia: STS-135 (drug)
N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 3 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
US: [proposed] CSA Schedule I Section g Subsection 18 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)
N-(Adamantan-1-yl)-1-pentylindole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 9 N-(Adamantan-1-yl)-1-pentylindole-3-carboxamide
3-(1-Adamantoyl)indole
UK: MDA Part II Class B Section 1(c) 3-(1-Adamantoyl)indole
3-(2-Adamantoyl)indole
UK: MDA Part II Class B Section 1(c) 3-(2-Adamantoyl)indole
N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 3 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
US: [proposed] CSA Schedule I Section g Subsection 18 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)
ADB-PINACA†
US: CSA Schedule I Section h Subsection 10 N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
AET
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
AH-7921
EU: Substances Substances 3,4-Dichloro-N-[[1-dimethylamino) cyclohexyl]methyl] benzamide
UK: MDA Part I Class A Section 1(a) 3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
AL-422
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
AL-463
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
AL-464
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
ALD-52
UK: MDA Part I Class A Section 1(a) (6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Alfaxalone
US: CSA Schedule IV Section c Subsection 1 Alfaxalone
Alfentanil
CA: CDSA Schedule I Section 16 Subsection 2 Alfentanil
UK: MDA Part I Class A Section 1(a) Alfentanil
UN: Narcotics Part 1 Section 1 Alfentanil
US: CSA Schedule II Section c Subsection 1 Alfentanil
Allobarbital
CA: CDSA Schedule IV Section 1 Subsection 1 Allobarbital
UN: Psychotropics Schedule IV Allobarbital
Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
UK: MDA Part I Class A Section 1(ba) Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
N-Allylnormorphine
CA: CDSA Schedule I Section 1 Subsection 23 Nalorphine
US: CSA Schedule III Section d Subsection d Nalorphine
Allylprodine
CA: CDSA Schedule I Section 3 Subsection 1 Allylprodine
UK: MDA Part I Class A Section 1(a) Allylprodine
UN: Narcotics Part 1 Section 1 Allylprodine
US: CSA Schedule I Section b Subsection 3 Allylprodine
Alphacetylmethadol
CA: CDSA Schedule I Section 6 Subsection 2 Alphacetylmethadol
UK: MDA Part I Class A Section 1(a) Alphacetylmethadol
UN: Narcotics Part 1 Section 1 Alphacetylmethadol
US: CSA Schedule I Section b Subsection 4 Alphacetylmethadol
Alpha-ethyltryptamine
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Alphameprodine
CA: CDSA Schedule I Section 3 Subsection 2 Alphameprodine
UK: MDA Part I Class A Section 1(a) Alphameprodine
UN: Narcotics Part 1 Section 1 Alphameprodine
US: CSA Schedule I Section b Subsection 5 Alphameprodine
Alphamethadol
CA: CDSA Schedule I Section 6 Subsection 3 Alphamethadol
UK: MDA Part I Class A Section 1(a) Alphamethadol
UN: Narcotics Part 1 Section 1 Alphamethadol
US: CSA Schedule I Section b Subsection 6 Alphamethadol
Alpha-Methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
Alpha-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
Alphamethylfentanyl‡
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
Alpha-Methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
Alpha-methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
Alphamethylthiofentanyl‡
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
Alpha-methyltryptamine
US: CSA Schedule I Section d Subsection 16 Alpha-methyltryptamine
Alphaprodine
CA: CDSA Schedule I Section 3 Subsection 3 Alphaprodine
UK: MDA Part I Class A Section 1(a) Alphaprodine
UN: Narcotics Part 1 Section 1 Alphaprodine
US: CSA Schedule II Section c Subsection 2 Alphaprodine
alpha-Pyrrolidinobutiophenone
US: CSA Schedule I Section h Subsection 20 alpha-Pyrrolidinobutiophenone
alpha-Pyrrolidinopentiophenone
US: CSA Schedule I Section h Subsection 13 alpha-Pyrrolidinopentiophenone
⇒
PubChem: 11148955; ChemSpider: 9324063; Drugs Forum: ?-PVP; Wikipedia: alpha-Pyrrolidinopentiophenone
Alprazolam
CA: CDSA Schedule IV Section 18 Subsection 1 Alprazolam
UK: MDA Part III Class C Section 1(a) Alprazolam
UN: Psychotropics Schedule IV Alprazolam
US: CSA Schedule IV Section c Subsection 2 Alprazolam
⇒
PubChem: 2118; ChemSpider: 2034; Bluelight: Alprazolam; Drugs Forum: Alprazolam; Erowid: Alprazolam; Wikipedia: Alprazolam
AM-1220
CA: CDSA Schedule II Section 2 Subsection 2 1-[(N-Methylpiperidin-2-yl)methyl]-3(1-naphthoyl)indole
AM2201†
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) AM-2201
US: CSA Schedule I Section g Subsection 11 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
AM-2201
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) AM-2201
US: CSA Schedule I Section g Subsection 11 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
AM-2233
CA: CDSA Schedule II Section 2 Subsection 5 1-(1-Methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole
AM678†
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-018
US: CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
Amfepramone
CA: CDSA Schedule IV Section 4 Diethylpropion
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
Amfetamine
CA: CDSA Schedule I Section 19 Subsection 1 Amphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 1 Amphetamine
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: AmphetamineAmidones
CA: CDSA Schedule I Section 5 Amidones
Amineptine
CA: CDSA Schedule III Section 32 Amineptine
UK: MDA Part III Class C Section 1(a) Amineptine
UN: Psychotropics Schedule II Amineptine
N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 9 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
UK: MDA Part I Class A Section 1(ba) 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
UK: MDA Part I Class A Section 1(ba) 2-Amino-1-(3,4-dimethoxyphenyl)ethanol
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
US: [proposed] CSA Schedule I Section h Subsection 25 N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 10 N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 21 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 9 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 22 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
2-Amino-2-phenylcyclohexanone
UK: MDA Part II Class B Section 1(d) 2-Amino-2-phenylcyclohexanone
2-Amino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(aa) 2-Amino-1-phenyl-1-propanone
2-Aminopropan-1-one
UK: MDA Part II Class B Section 1(ab) 2-Aminopropan-1-one
Amobarbital
CA: CDSA Schedule IV Section 1 Subsection 3 Amobarbital
UN: Psychotropics Schedule III Amobarbital
US: CSA Schedule II Section e Subsection 1 Amobarbital, Schedule III Section c Subsection 1 Item i Amobarbital and Subsection 2 Item i Amobarbital
Amphetamine
CA: CDSA Schedule I Section 19 Subsection 1 Amphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 1 Amphetamine
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: AmphetamineAmphetamines
CA: CDSA Schedule I Section 19 Amphetamines
CA: [revoked] CDSA Schedule III Section 1 Amphetamines
Ampromides
CA: CDSA Schedule I Section 12 Ampromides
AMT
US: CSA Schedule I Section d Subsection 16 Alpha-methyltryptamine
Anabolic steroids
CA: CDSA Schedule IV Section 23 Anabolic steroids
Androisoxazole
CA: CDSA Schedule IV Section 23 Subsection 1 Androisoxazole
5α-Androstan-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 3 5α-Androstan-3,17-dione
5α-Androstane-3,17-diol
UK: MDA Part III Class C Section 1(b) 5α-Androstane-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 2 3α,17β-Dihydroxy-5α-androstane
Androstanolone
CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
UK: MDA Part III Class C Section 1(b) Stanolone
US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
5α-Androstan-3,6,17-trione
US: CSA Schedule III Section f Subsection 1 Item 65 5α-Androstan-3,6,17-trione
Androstenediol
CA: CDSA Schedule IV Section 23 Subsection 3 Androstenediol
UK: MDA Part III Class C Section 1(b) 5-Androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 7 5-Androstenediol
1-Androstenediol
US: CSA Schedule III Section f Subsection 1 Item 4 1-Androstenediol
1-Androstenediol
UK: MDA Part III Class C Section 1(b) 1-Androstenediol
US: CSA Schedule III Section f Subsection 1 Item 5 1-Androstenediol
4-Androstenediol
UK: MDA Part III Class C Section 1(b) Androst-4-ene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 6 4-Androstenediol
Androst-4-ene-3,17-diol
UK: MDA Part III Class C Section 1(b) Androst-4-ene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 6 4-Androstenediol
5-Androstenediol
CA: CDSA Schedule IV Section 23 Subsection 3 Androstenediol
UK: MDA Part III Class C Section 1(b) 5-Androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 7 5-Androstenediol
5-Androstene-3,17-diol
CA: CDSA Schedule IV Section 23 Subsection 3 Androstenediol
UK: MDA Part III Class C Section 1(b) 5-Androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 7 5-Androstenediol
Androstenedione‡
UK: MDA Part III Class C Section 1(b) 4-Androstene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 9 4-Androstenedione
1-Androstenedione
UK: MDA Part III Class C Section 1(b) 1-Androstenedione
US: CSA Schedule III Section f Subsection 1 Item 8 1-Androstenedione
4-Androstenedione
UK: MDA Part III Class C Section 1(b) 4-Androstene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 9 4-Androstenedione
4-Androstene-3,17-dione
UK: MDA Part III Class C Section 1(b) 4-Androstene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 9 4-Androstenedione
5-Androstenedione
UK: MDA Part III Class C Section 1(b) 5-Androstenedione
US: CSA Schedule III Section f Subsection 1 Item 10 5-Androstenedione
Anileridine
CA: CDSA Schedule I Section 3 Subsection 4 Anileridine
UK: MDA Part I Class A Section 1(a) Anileridine
UN: Narcotics Part 1 Section 1 Anileridine
US: CSA Schedule II Section c Subsection 3 Anileridine
4-Anilino-N-phenylethyl-4-piperidine
US: CSA Schedule II Section g Subsection 3 Item i 4-Anilino-N-phenylethyl-4-piperidine
ANPP
US: CSA Schedule II Section g Subsection 3 Item i 4-Anilino-N-phenylethyl-4-piperidine
Anthranilic acid
CA: CDSA Schedule VI Part 1 Subsection 3 Anthranilic acid
EU: Drug precursors Annex I Category 2 Anthranilic acid and Annex II Anthranilic acid
UK: MDA Drug precursors Annex I Category 2 Anthranilic acid and Drug precursors Annex II Anthranilic acid
UN: Precursors Table II Anthranilic acid
US: CSA Listed Chemicals Section a Subsection 1 Anthranilic acid
APICA
CA: CDSA Schedule II Section 2 Subsection 9 N-(Adamantan-1-yl)-1-pentylindole-3-carboxamide
APINACA
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
US: CSA Schedule I Section h Subsection 3 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
US: [proposed] CSA Schedule I Section g Subsection 18 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)
Apomorphine
CA: [not controlled] CDSA Schedule I Section 1 Subsection 32 Apomorphine
Aprobarbital
CA: CDSA Schedule IV Section 1 Subsection 4 Aprobarbital
Atamestane
UK: MDA Part III Class C Section 1(b) Atamestane
Atropine sulfate
UN: Narcotics Part 2 Section 5 Atropine sulfate and Section 6 Atropine sulfate
US: CSA Schedule IV Section b Subsection 1 Atropine sulfate, Schedule V Section c Subsection 4 Atropine sulfate and Subsection 6 Atropine sulfate
Barbiturates
CA: CDSA Schedule IV Section 1 Barbiturates
UK: MDA Part II Class B Section 1(b) Barbituric acid [5,5-disubstituted]
Barbituric acid
CA: CDSA Schedule IV Section 1 Subsection 6 Barbituric acid
US: CSA Schedule III Section c Subsection 3 Barbituric acid
Barbituric acid [5,5-disubstituted]
CA: CDSA Schedule IV Section 1 Barbiturates
UK: MDA Part II Class B Section 1(b) Barbituric acid [5,5-disubstituted]
Benzaldehyde
US: CSA Listed Chemicals Section a Subsection 22 Benzaldehyde
Benzazocines
CA: CDSA Schedule I Section 11 Benzazocines
Benzeneacetic acid
CA: CDSA Schedule VI Part 1 Subsection 12 Phenylacetic acid
EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
UK: MDA Drug precursors Annex I Category 2 Phenylacetic acid and Drug precursors Annex II Phenylacetic acid
UN: Precursors Table II Phenylacetic acid
US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
⇒
PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
Benzethidine
CA: CDSA Schedule I Section 3 Subsection 7 Benzethidine
UK: MDA Part I Class A Section 1(a) Benzethidine
UN: Narcotics Part 1 Section 1 Benzethidine
US: CSA Schedule I Section b Subsection 9 Benzethidine
Benzfetamine
CA: CDSA Schedule I Section 19 Subsection 17 Benzphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 18 Benzphetamine
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
US: CSA Schedule III Section b Subsection 2 Benzphetamine
Benzimidazoles
CA: CDSA Schedule I Section 13 Benzimidazoles
Benzodiazepines
CA: CDSA Schedule IV Section 18 Benzodiazepines
1-Benzofuran
UK: MDA Part II Class B Section 1(e) 1-Benzofuran
1-(Benzofuran-5-yl)-propan-2-amine
UK: MDA Part II Class B Section 1(e) 1-(Benzofuran-5-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(Benzofuran-5-yl)-propan-2-amine
1-(Benzofuran-6-yl)-propan-2-amine
UK: MDA Part II Class B Section 1(e) 1-(Benzofuran-6-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(Benzofuran-6-yl)-propan-2-amine
3-Benzoylindole
CA: CDSA Schedule II Section 2 Subsection 5 3-Benzoylindole
UK: MDA Part II Class B Section 1(c) 3-Benzoylindole
US: CSA Schedule I Section v Item v 3-Benzoylindole
Benzphetamine
CA: CDSA Schedule I Section 19 Subsection 17 Benzphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 18 Benzphetamine
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
US: CSA Schedule III Section b Subsection 2 Benzphetamine
Benzyl chloride
US: CSA Listed Chemicals Section b Subsection 3 Benzyl chloride
Benzyl cyanide
US: CSA Listed Chemicals Section a Subsection 2 Benzyl cyanide
Benzyl methyl ketone
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
Benzylfentanyl
Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
UK: MDA Part I Class A Section 1(ba) Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
PubChem: 20507314; ChemSpider: 15110233; PiHKAL • info: MDBZ; Wikipedia: Methylenedioxybenzylamphetamine
Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
UK: MDA Part I Class A Section 1(f) Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Benzylmorphine
CA: CDSA Schedule I Section 1 Subsection 7 Benzylmorphine
UK: MDA Part I Class A Section 1(a) Benzylmorphine
UN: Narcotics Part 1 Section 1 Benzylmorphine
US: CSA Schedule I Section c Subsection 3 Benzylmorphine
3-Benzylmorphine
CA: CDSA Schedule I Section 1 Subsection 7 Benzylmorphine
UK: MDA Part I Class A Section 1(a) Benzylmorphine
UN: Narcotics Part 1 Section 1 Benzylmorphine
US: CSA Schedule I Section c Subsection 3 Benzylmorphine
N-Benzylphenethylamine
UK: MDA Part I Class A Section 1(f) N-Benzylphenethylamine
Benzylpiperazine
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
1-Benzylpiperazine
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
N-Benzylpiperazine
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
N-[1-Benzyl-4-piperidyl]-N-phenylpropanamide
Betacetylmethadol
CA: CDSA Schedule I Section 6 Subsection 4 Betacetylmethadol
UK: MDA Part I Class A Section 1(a) Betacetylmethadol
UN: Narcotics Part 1 Section 1 Betacetylmethadol
US: CSA Schedule I Section b Subsection 10 Betacetylmethadol
Beta-Hydroxyfentanyl
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
Beta-hydroxyfentanyl
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
Betahydroxyfentanyl‡
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
Beta-Hydroxy-3-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
Beta-hydroxy-3-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
Betameprodine
CA: CDSA Schedule I Section 3 Subsection 5 Betameprodine
UK: MDA Part I Class A Section 1(a) Betameprodine
UN: Narcotics Part 1 Section 1 Betameprodine
US: CSA Schedule I Section b Subsection 13 Betameprodine
Betamethadol
CA: CDSA Schedule I Section 6 Subsection 5 Betamethadol
UK: MDA Part I Class A Section 1(a) Betamethadol
UN: Narcotics Part 1 Section 1 Betamethadol
US: CSA Schedule I Section b Subsection 14 Betamethadol
Betaprodine
CA: CDSA Schedule I Section 3 Subsection 6 Betaprodine
UK: MDA Part I Class A Section 1(a) Betaprodine
UN: Narcotics Part 1 Section 1 Betaprodine
US: CSA Schedule I Section b Subsection 15 Betaprodine
Bezitramide
CA: CDSA Schedule I Section 13 Subsection 3 Bezitramide
UK: MDA Part I Class A Section 1(a) Bezitramide
UN: Narcotics Part 1 Section 1 Bezitramide
US: CSA Schedule II Section c Subsection 4 Bezitramide
BMK (Benzyl methyl ketone)†
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
BOB†
UK: MDA Part I Class A Section 1(ba) 4-Bromo-β,2,5-trimethoxyphenethylamine
BOD†
UK: MDA Part I Class A Section 1(ba) β,2,5-Trimethoxy-4-methylphenethylamine
BOH†
UK: MDA Part I Class A Section 1(ba) β-Methoxy-3,4-methylenedioxyphenethylamine
BOHD†
UK: MDA Part I Class A Section 1(ba) 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
Bolasterone
CA: CDSA Schedule IV Section 23 Subsection 5 Bolasterone
UK: MDA Part III Class C Section 1(b) Bolasterone
US: CSA Schedule III Section f Subsection 1 Item 11 Bolasterone
Bolenol
Bolmantalate
UK: MDA Part III Class C Section 1(b) Bolmantalate
BOM†
UK: MDA Part I Class A Section 1(ba) β,3,4,5-Tetramethoxyphenethylamine
Brolamfetamine
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
Bromazepam
CA: CDSA Schedule IV Section 18 Subsection 2 Bromazepam
UK: MDA Part III Class C Section 1(a) Bromazepam
UN: Psychotropics Schedule IV Bromazepam
US: CSA Schedule IV Section c Subsection 4 Bromazepam
⇒
PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
6-Bromo-androsta-1,4-diene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 67 6-Bromo-androsta-1,4-diene-3,17-dione
6-Bromo-androstan-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 66 6-Bromo-androstan-3,17-dione
7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
UK: MDA Part III Class C Section 1(a) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
⇒
PubChem: 40113; ChemSpider: 36657; Bluelight: Phenazepam; Drugs Forum: Phenazepam; Erowid: Phenazepam; Wikipedia: Phenazepam
4-Bromo-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxybenzeneethanamine
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
4-Bromo-2,5-dimethoxy-α-methylphenethylamine
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyphenethylamine
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
4-Bromo-β,2,5-trimethoxyphenethylamine
UK: MDA Part I Class A Section 1(ba) 4-Bromo-β,2,5-trimethoxyphenethylamine
Brotizolam
CA: CDSA Schedule IV Section 18 Subsection 2.1 Brotizolam
UK: MDA Part III Class C Section 1(a) Brotizolam
UN: Psychotropics Schedule IV Brotizolam
Bufotenin‡
UK: MDA Part I Class A Section 1(a) Bufotenine
US: CSA Schedule I Section d Subsection 17 Bufotenine
Bufotenine
UK: MDA Part I Class A Section 1(a) Bufotenine
US: CSA Schedule I Section d Subsection 17 Bufotenine
Buprenorphine
CA: CDSA Schedule I Section 10 Subsection 1 Buprenorphine
UK: MDA Part III Class C Section 1(a) Buprenorphine
UN: Psychotropics Schedule III Buprenorphine
US: CSA Schedule III Section e Subsection 2 Item i Buprenorphine
⇒
PubChem: 40400 644073; ChemSpider: 559124; Bluelight: Buprenorphine; Drugs Forum: Buprenorphine; Erowid: Buprenorphine; Wikipedia: Buprenorphine
Butabarbital
CA: CDSA Schedule IV Section 1 Subsection 7 Butabarbital
UN: Psychotropics Schedule IV Secbutabarbital
Butalbital
CA: CDSA Schedule IV Section 1 Subsection 8 Butalbital
UN: Psychotropics Schedule III Butalbital
Butallylonal
CA: CDSA Schedule IV Section 1 Subsection 9 Butallylonal
1,4-Butanediol
CA: CDSA Schedule VI Part 1 Subsection 19 1,4-Butanediol
UK: MDA Part III Class C Section 1(b) 1,4-Butanediol
⇒
PubChem: 8064; ChemSpider: 13835209; Drugs Forum: 1,4-Butanediol; Erowid: 1,4-Butanediol; Wikipedia: 1,4-Butanediol
1,2-Butanolide
CA: CDSA Schedule VI Part 1 Subsection 18 Gamma-butyrolactone
UK: MDA Part III Class C Section 1(a) Gamma-butyrolactone
US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
1,4-Butanolide
CA: CDSA Schedule VI Part 1 Subsection 18 Gamma-butyrolactone
UK: MDA Part III Class C Section 1(a) Gamma-butyrolactone
US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
Butanone
CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
UN: Precursors Table II Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
2-Butanone
CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
UN: Precursors Table II Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
Butethal
CA: CDSA Schedule IV Section 1 Subsection 10 Butethal
UN: Psychotropics Schedule IV Butobarbital
Butobarbital
CA: CDSA Schedule IV Section 1 Subsection 10 Butethal
UN: Psychotropics Schedule IV Butobarbital
Butorphanol
CA: [not controlled] CDSA Schedule I Section 10 Subsection 14 Butorphanol
Butorphanol
CA: CDSA Schedule IV Section 9 Butorphanol
US: CSA Schedule IV Section g Subsection 2 Butorphanol
1-Butyl-3-(4-methoxy-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-081
US: CSA Schedule I Section g Subsection 8 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
1-Butyl-3-(4-methoxy-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
1-Butyl-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-073
US: CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
⇒
PubChem: 10471670; ChemSpider: 8647081; Bluelight: JWH-073; Erowid: Spice Product; Wikipedia: JWH-073
N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
UK: MDA Part I Class A Section 1(ba) N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
BZP
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
Calusterone
CA: CDSA Schedule IV Section 23 Subsection 9 Calusterone
UK: MDA Part III Class C Section 1(b) Calusterone
US: CSA Schedule III Section f Subsection 1 Item 14 Calusterone
Cannabicyclohexanol
UK: MDA Part II Class B Section 1(c) CP 47,497-C8
US: CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
Cannabidiol
CA: CDSA Schedule II Section 1 Subsection 3 Cannabidiol
⇒
PubChem: 644019 26346; ChemSpider: 559095; Drugs Forum: Cannabidiol; Erowid: Cannabis; Wikipedia: Cannabidiol
Cannabinol
CA: CDSA Schedule II Section 1 Subsection 4 Cannabinol
UK: MDA Part II Class B Section 1(a) Cannabinol and Cannabinol
Cannabinol derivatives
UK: MDA Part II Class B Section 1(a) Cannabinol derivatives
Cannabis resin
CA: CDSA Schedule II Section 1 Subsection 1 Cannabis resin, Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
UK: MDA Part II Class B Section 1(a) Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
Cannabis seed, non-viable
CA: [not controlled] CDSA Schedule II Section 1 Subsection 8 Non-viable Cannabis seed
Cannabis stalks
CA: [not controlled] CDSA Schedule II Section 1 Subsection 9 Cannabis stalks
Carbamethidine
CA: [not controlled] CDSA Schedule I Section 3 Subsection 23 Carbamethidine
3-Carboxamideindazole
CA: CDSA Schedule II Section 2 Subsection 8 3-Carboxamideindazole
3-Carboxamideindole
CA: CDSA Schedule II Section 2 Subsection 9 3-Carboxamideindole
Carfentanil
CA: CDSA Schedule I Section 16 Subsection 3 Carfentanil
UK: MDA Part I Class A Section 1(a) Carfentanil
US: CSA Schedule II Section c Subsection 6 Carfentanil
Carisoprodol
US: CSA Schedule IV Section c Subsection 6 Carisoprodol
Carperidine‡
CA: [not controlled] CDSA Schedule I Section 3 Subsection 23 Carbamethidine
Catha edulis
CA: CDSA Schedule IV Section 19 Catha edulis
UK: MDA Part III Class C Section 1(a) Khat
Cathine
CA: CDSA Schedule IV Section 19 Subsection 1 Cathine
UK: MDA Part III Class C Section 1(a) Cathine
UN: Psychotropics Schedule III Cathine ((+)-Norpseudoephedrine)
US: CSA Schedule IV Section f Subsection 1 Cathine
Chloral betaine
US: CSA Schedule IV Section c Subsection 7 Chloral betaine
Chloral hydrate
US: CSA Schedule IV Section c Subsection 8 Chloral hydrate
⇒
PubChem: 2707; ChemSpider: 2606; Drugs Forum: Chloral Hydrate; Erowid: Chloral hydrate; Wikipedia: Chloral hydrate
Chloralodol‡
US: CSA Schedule III Section c Subsection 4 Chlorhexadol
Chlordiazepoxide
CA: CDSA Schedule IV Section 18 Subsection 4 Chlordiazepoxide
UK: MDA Part III Class C Section 1(a) Chlordiazepoxide
UN: Psychotropics Schedule IV Chlordiazepoxide
US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
⇒
PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
Chlorhexadol
US: CSA Schedule III Section c Subsection 4 Chlorhexadol
4-Chlorodehydromethyltestosterone‡
UK: MDA Part III Class C Section 1(b) 4-Chloromethandienone
US: CSA Schedule III Section f Subsection 1 Item 16 Dehydrochloromethyltestosterone
⇒
PubChem: 16395944; ChemSpider: 88972; Erowid: Steroids; Wikipedia: 4-Chlorodehydromethyltestosterone
4-Chloro-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 16 4-Chloro-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
4-Chloro-2,5-dimethoxyphenethylamine
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 40 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 40 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
4-Chloromethandienone
UK: MDA Part III Class C Section 1(b) 4-Chloromethandienone
US: CSA Schedule III Section f Subsection 1 Item 16 Dehydrochloromethyltestosterone
⇒
PubChem: 16395944; ChemSpider: 88972; Erowid: Steroids; Wikipedia: 4-Chlorodehydromethyltestosterone
4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol
US: CSA Schedule III Section f Subsection 1 Item 68 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol and Item 72 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol
4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol
US: CSA Schedule III Section f Subsection 1 Item 69 4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol
4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione
US: CSA Schedule III Section f Subsection 1 Item 71 4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione
4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one
US: CSA Schedule III Section f Subsection 1 Item 70 4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one
Chlorphentermine
CA: CDSA Schedule IV Section 3 Chlorphentermine
UK: MDA Part III Class C Section 1(a) Chlorphentermine
US: CSA Schedule III Section b Subsection 3 Chlorphentermine
Chorionic gonadotrophin
UK: MDA Part III Class C Section 1(e) Chorionic gonadotrophin
Cimbi-36
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Cimbi-5
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Cimbi-82
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Clenbuterol
UK: MDA Part III Class C Section 1(e) Clenbuterol
Clonazepam
CA: CDSA Schedule IV Section 18 Subsection 6 Clonazepam
UK: MDA Part III Class C Section 1(a) Clonazepam
UN: Psychotropics Schedule IV Clonazepam
US: CSA Schedule IV Section c Subsection 11 Clonazepam
⇒
PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
Clonitazene
CA: CDSA Schedule I Section 13 Subsection 1 Clonitazene
UK: MDA Part I Class A Section 1(a) Clonitazene
UN: Narcotics Part 1 Section 1 Clonitazene
US: CSA Schedule I Section b Subsection 16 Clonitazene
Clorazepate
CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
Clorazepate
CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
UK: MDA Part III Class C Section 1(a) Clorazepic acid
UN: Psychotropics Schedule IV Clorazepate
US: CSA Schedule IV Section c Subsection 12 Clorazepate
Clorazepic acid
CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
UK: MDA Part III Class C Section 1(a) Clorazepic acid
UN: Psychotropics Schedule IV Clorazepate
US: CSA Schedule IV Section c Subsection 12 Clorazepate
Clortermine
US: CSA Schedule III Section b Subsection 4 Clortermine
Clotiazepam
CA: CDSA Schedule IV Section 12 Clotiazepam
UK: MDA Part III Class C Section 1(a) Clotiazepam
UN: Psychotropics Schedule IV Clotiazepam
US: CSA Schedule IV Section c Subsection 13 Clotiazepam
Cloxazolam
CA: CDSA Schedule IV Section 18 Subsection 8 Cloxazolam
UK: MDA Part III Class C Section 1(a) Cloxazolam
UN: Psychotropics Schedule IV Cloxazolam
US: CSA Schedule IV Section c Subsection 14 Cloxazolam
Coca leaf
CA: CDSA Schedule I Section 2 Subsection 1 Coca leaves
UK: MDA Part I Class A Section 1(a) Coca leaf
UN: Narcotics Part 1 Section 1 Coca leaf
US: CSA Schedule II Section b Subsection 4 Coca leaves
Coca leaves
CA: CDSA Schedule I Section 2 Subsection 1 Coca leaves
UK: MDA Part I Class A Section 1(a) Coca leaf
UN: Narcotics Part 1 Section 1 Coca leaf
US: CSA Schedule II Section b Subsection 4 Coca leaves
Codeine methylbromide
US: CSA Schedule I Section c Subsection 4 Codeine methylbromide
Codeine-N-oxide
UN: Narcotics Part 1 Section 1 Codeine-N-oxide
US: CSA Schedule I Section c Subsection 5 Codeine-N-oxide
Concentrate of poppy straw
UK: MDA Part I Class A Section 1(a) Concentrate of poppy-straw
UN: Narcotics Part 1 Section 1 Concentrate of poppy straw
US: CSA Schedule II Section b Subsection 5 Concentrate of poppy straw
Concentrate of poppy-straw
UK: MDA Part I Class A Section 1(a) Concentrate of poppy-straw
UN: Narcotics Part 1 Section 1 Concentrate of poppy straw
US: CSA Schedule II Section b Subsection 5 Concentrate of poppy straw
CP 47,497
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) CP 47,497
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
CP 47,497-C8
UK: MDA Part II Class B Section 1(c) CP 47,497-C8
US: CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
4-Cyano-2-dimethylamino-4,4-diphenylbutane
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
4-Cyano-1-methyl-4-phenylpiperidine
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
Cyclazocine
CA: [not controlled] CDSA Schedule I Section 11 Subsection 4 Cyclazocine
⇒
PubChem: 24039373 24013863 23986637 23955932 21779964 11957515 10038849 10016044 3037926; ChemSpider: 2301549; Wikipedia: Cyclazocine
Cyclobarbital
CA: CDSA Schedule IV Section 1 Subsection 11 Cyclobarbital
UN: Psychotropics Schedule III Cyclobarbital
Cyclohexamine
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine
UK: MDA Part I Class A Section 1(a) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine
2-(Cyclohexyl)phenol
CA: CDSA Schedule II Section 2 Subsection 1 2-(Cyclohexyl)phenol
Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
UK: MDA Part I Class A Section 1(ba) Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Cyprenorphine
CA: [not controlled] CDSA Schedule I Section 1 Subsection 33 Cyprenorphine
US: CSA Schedule I Section c Subsection 6 Cyprenorphine
Dalmane®
CA: CDSA Schedule IV Section 18 Subsection 15 Flurazepam
UK: MDA Part III Class C Section 1(a) Flurazepam
UN: Psychotropics Schedule IV Flurazepam
US: CSA Schedule IV Section c Subsection 24 Flurazepam
Danazol
UK: MDA Part III Class C Section 1(b) Danazol
⇒
PubChem: 667474 16757656 11957530 11874041 11869648 11416460 7078889 7061279 6540825 28417; ChemSpider: 26436; Wikipedia: Danazol
3,4-DCMP
UK: MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
Dehydrochloromethyltestosterone
UK: MDA Part III Class C Section 1(b) 4-Chloromethandienone
US: CSA Schedule III Section f Subsection 1 Item 16 Dehydrochloromethyltestosterone
⇒
PubChem: 16395944; ChemSpider: 88972; Erowid: Steroids; Wikipedia: 4-Chlorodehydromethyltestosterone
Dehydroepiandrosterone‡
CA: CDSA Schedule IV Section 23 Subsection 36 Prasterone
UK: MDA Part III Class C Section 1(b) Prasterone
Delorazepam
CA: CDSA Schedule IV Section 18 Subsection 9 Delorazepam
UK: MDA Part III Class C Section 1(a) Delorazepam
UN: Psychotropics Schedule IV Delorazepam
US: CSA Schedule IV Section c Subsection 15 Delorazepam
delta-9-Tetrahydrocannabinol
UN: Psychotropics Schedule II Dronabinol (delta-9-Tetrahydrocannabinol)
US: CSA Schedule III Section g Subsection 1 Dronabinol
N-Demethylcodeine
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UK: MDA Part II Class B Section 1(a) Norcodeine
UN: Narcotics Part 1 Section 2 Norcodeine and Part 2 Section 1 Norcodeine
Demethylmorphine
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UK: MDA Part I Class A Section 1(a) Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
N-Desmethylcodeine
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UK: MDA Part II Class B Section 1(a) Norcodeine
UN: Narcotics Part 1 Section 2 Norcodeine and Part 2 Section 1 Norcodeine
N-Desmethylmorphine
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UK: MDA Part I Class A Section 1(a) Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
Desomorphine
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UK: MDA Part I Class A Section 1(a) Desomorphine
UN: Narcotics Part 1 Section 1 Desomorphine and Section 3 Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
Desoxymethyltestosterone
UK: MDA Part III Class C Section 1(b) Desoxymethyltestosterone
US: CSA Schedule III Section f Subsection 1 Item 17 Desoxymethyltestosterone
DET
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
Dexamfetamine
UN: Psychotropics Schedule II Dexamfetamine (Dexamphetamine)
Dexamphetamine
UN: Psychotropics Schedule II Dexamfetamine (Dexamphetamine)
Dextroamphetamine‡
UN: Psychotropics Schedule II Dexamfetamine (Dexamphetamine)
Dextromethorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 10 Dextromethorphan
UK: MDA Part I Class A Section 2 Dextromethorphan
⇒
PubChem: 5360696; ChemSpider: 13109865; Bluelight: DXM; Drugs Forum: DXM; Wikipedia: Dextromethorphan
Dextromoramide
CA: CDSA Schedule I Section 9 Subsection 1 Dextromoramide
UK: MDA Part I Class A Section 1(a) Dextromoramide
UN: Narcotics Part 1 Section 1 Dextromoramide
US: CSA Schedule I Section b Subsection 17 Dextromoramide
Dextropropoxyphene
CA: CDSA Schedule I Section 7 Subsection 3 Dextropropoxyphene
UK: MDA Part III Class C Section 1(a) Dextropropoxyphene
UN: Narcotics Part 1 Section 2 Dextropropoxyphene and Part 2 Section 3 Dextropropoxyphene
US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
Dextrorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 11 Dextrorphan
UK: MDA Part I Class A Section 2 Dextrorphan
Diacetylmorphine
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
US: CSA Schedule I Section c Subsection 11 Heroin
Diamorphine
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
US: CSA Schedule I Section c Subsection 11 Heroin
Diampromide
CA: CDSA Schedule I Section 12 Subsection 1 Diampromide
UK: MDA Part I Class A Section 1(a) Diampromide
UN: Narcotics Part 1 Section 1 Diampromide
US: CSA Schedule I Section b Subsection 18 Diampromide
Dichloralphenazone
US: CSA Schedule IV Section c Subsection 17 Dichloralphenazone
3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
EU: Substances Substances 3,4-Dichloro-N-[[1-dimethylamino) cyclohexyl]methyl] benzamide
UK: MDA Part I Class A Section 1(a) 3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
3,4-Dichloromethylphenidate
UK: MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
Diethyl ether
CA: CDSA Schedule VI Part 2 Subsection 2 Ethyl ether
EU: Drug precursors Annex I Category 3 Ethyl ether
UK: MDA Drug precursors Annex I Category 3 Ethyl ether
UN: Precursors Table II Ethyl ether
US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
![3D rendering of (6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide](data:image/png;base64,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 "Click for a 3D rendering of (6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide")
(6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
UK: MDA Part I Class A Section 1(a) (6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Diethylcathinone‡
CA: CDSA Schedule IV Section 4 Diethylpropion
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
![3D rendering of (6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide](data:image/png;base64,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 "Click for a 3D rendering of (6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide")
(6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
UK: MDA Part I Class A Section 1(a) (6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Diethylpropion
CA: CDSA Schedule IV Section 4 Diethylpropion
UK: MDA Part II Class B Section 1(aa) Diethylpropion and Part III Class C Section 1(a) Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
![3D rendering of (6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMQAAADkCAIAAABIaBwKAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC43MQM/aDQAAA+gSURBVHic7Z2/z+NEE8cn6K1Be0jQUJzskxAlsvtrnJ4mDwXtgy1Eg0DI+QeQ7BM1kq1HokJCcU9jN9DQ2LriCo4Tsa64ErIIUZ/fYsEXNs+PJN5f3p1PlSd3j7158vXs7OzszGIYBkAQEbymewCIPaCYEGGgmBBhoJgQYdgspqZpkiTRPQqHsFlMhJCyLMuy1D0QV1jYHRpIkqRpmrZtCSG6x2I/NlsmAMiyjFKa57nugTiB5WIihMRxXJZl3/e6x2I/lk9zDN/3gyDYbDa6B2I5llsmRpZlVVU1TaN7IJbjhGUCgOVySSlt21b3QGzGCcsEAEVRdF2HYQKpuGKZAGC9Xpdlud1uMUwgCVcsEwCkaQoAGCaQh0NiIoSkaZrnOYYJJOHQNMfwfd/zvLqudQ/EQhyyTIyiKJqmwTCBDJyzTABwcXHRdd12u9U9ENtwzjIBQJZlfd+jJy4cFy0TYJhADi5aJsAwgRwcFRMhJMuyPM+7rtM9FntwdJpjhGFICMEwgSg0WKau6wwJG2ZZ1jRNVVW6B2IJGsSU5/lyuVR/30OCICCEGKJsGxiUwwI8WZapvzVHHMee5+12O90DsQQNYhqGIU1TQojeb5G5SkVRaByDZehxwCmlvu/HcZxlmfq7M9hUi963SHSpuCgKANhutxrv3ratlrvbis7QgK6VOaU0DMMoipikEGFoFDKT0WazUXxfEzw2K9EppmEYVquV53kq78j249I0VXlTR9AsJvVfLQsHKLudU2gW06B20tE1sTqC/r05le4wbsbJRbeah0HVQl1vMMIF9FsmhuwQoglhUvvRreZ/kL25geEABZiSHBdFURzHeZ5TSoVf/M8//ySE/PDDD5ikKxVTpjnAmWj+mGKZQGhhrsUC1mv+HUQ2Blkmhu/708MEiwV4HhQFRNGrdwz7oDai22njYfXd6rqechGAoa4HzxtGh9u8D2ohxlkmEFGYi9mhiwvwPGAOGFomFehW8zWcLaMxFZh9rO12IGRgoVAjP6htmGiZAKDv+zPc8AcPHty/fx/27FCeQ1VB26JlUoGhYprIvnTCEKII8hzFJB37xdQ0wA5W2fhBzcKgOJMkogjiWPcg3MBOy4RowX7LBAB//fVX0zQvXrzQPRDLcUJMr7/+elVVDx8+lLGLjIw4ISbA9k5KcEVM2N5JAW454NjeSSquWCYGtneSiluWCbC9k0zcskyA7Z1k4pxlAqzbLA3nLBNg3WZpuCgmbO8kCRfFBABpmnqelyTJ1AtRCkkC9+7BYgH37kGSgMNB9v/pHoA2iqJYLpeff/75kydPTv3d999//9GjR0Ap+D7EMbQteB70PZQl+D5st+CkN+aiA87o+/6LL75o2/ajjz469XcfPHhweXkJSQKEAHfKb70GSsHNmnT6MoY1E0XRG2+8AVPOpBMyHJbBYJnnTuKoZeq6LgxD9vqdd9759ttvo/GI3fHclFjuasK5oz7TftDyxYsXy+Xygw8+ePfdd4/89X+mOUKg78Hz/vNvfe+mwwRuiqnvey4C/vbbb//999/Hd3h6+fIlAMBqBWXJ+0xlCauVmIHODRfFxCmJEPLLL7+cEw3PMvB9AIA4frWaK0twtWGrc3EmSiknps1mc+a+CiGw3QKlEIawWEAYAqXOxgUA3FvNcSUxsIazQJxbzfm+P+6iRFGExVIF4tY0V1XVqCRCCKZcisUtMe17S+e7SsgNOCSmruvGhN00Tc+JUiK34pCYRrMURRGWzZSBKw543/e+7wMAIQRzLCXhimUazRK6SvJwQkxjoBJdJak4Iaaqqiil6CrJxgmfyfd9Sim6SrIxa6N3seDFffjOqbBAZV3XqCTZzGaae/bs2fj6pMo4ZVmiq6SG2Yjp6uqKvcjzfDxVUlXV+t++Fl3XjSIbX7AUJXSV1GDWNHcMlNJ9rYwZbev1OggCppskSYIgSNP066+//vTTT6dXqgiCwJBZ8jCz72yCIFgJzeMzTkwLES1zmOAuLi6qqvr++++nX9Cc/IIkSfq+97hc4XOxXEyHDvgZFyGE/PHHH1VV1XU93Vtqmma5XJZlGesu21uWZdM0bdsGQaB3JNejM5nqgMPxjO98+eWX7EWWZavVir1u23Y8qNS27djocrfbBUEQRZGogZnQwH6323meF8ex3mHcwmzE9Ouvv45v3tkdVXhvZxaj0puWaX5n2NmI6Xh2u52ML17vd2mCmu/ELDEJQdK3rneWWa1W2ufZO7FNTNvtFvZ6hYmFzZ4tazqmELaQ3Gw2iu97KrbtzV1cXHRdt5V2cm25XAKA4jBBGIaEEENiE7ehW80iYX/uiS1Zj7mFSiMhfDEhD6vEJDYccBMqwwSSFhOSsEdMyp5glQsr88MB+1giJsVPsJrvWOpiQgaWiEnxE6wmTDCLcMA+NohJyxMsO0ygYDEhHBtCA7LDATchNUwwm3DAPrrVPJU5PsF3wrKyZhEO2Gf2lmmWT/CtUEp934/jeH4JorrVPAld+xsjAAO3gpz+F51XOGCfGYvJhPwegMHzhv05dqKYmOd3fjVprcxYTPtP8Ha71eJhAAx1PXjeMNqRiWKKoigIgukD04JxabtHwvLq4zhmef5lWVZVpX5BBwBRBEEAec5X3b26uvrtt99OvVrTNPP1/+YqJo44jvM8z/Octf9STJZBGMJqBfuZ2c+ePXv8+PGpl5r3ET/dpvF8OEdVi986/v2ybGCz05z/olOZ8UfnHHAtG+z70gmCIU1RTLOFCw2ojxTsS6euBwCnxTT7oCW3p6E4hsm13EkSKEs3m/AAwPyfI6abMTAzl3RpK5m9ZQKAJEnYOVcWJmA/KggT2LeTMxXdahYA53qryYSc6V6sVGwQ0/BvXGD8amWHCeaVmq0MS8Q0DAMXJpC6bTffvVip2CMm1ghlTGySFyaY9V6sVGxwwEe4MIGkTMjlckkpbdtW7GVtQLeaRcK+YKlhAisTO0VhlZiGA2+GHZgU6Nx4njdWh0I4bBOT1DABS0nAcMBN2Cam4SACxEUNzgbDAXdioZiGg8nI87zpIjh7xjx0TC1zVUfs/FScmzw9qZdz7U/CHTFZFRrYR+wC/pgoA6tq3/c9awP88uXLR48egZweHmZiSdruIUVR+L7/8ccff/jhhxMv9dNPP42p2ZxiWEn7a4vWzzj79lzsfEQY77333tOnT4Vc6q233nr48CGl9PhmB2Md+mtLmVv5Z7fWMjVN8/TpU4FF5Ver1VjPf98+sReU0rHxxiGH09zEIZmJtZZJbLLR8TlSzHR1Xffmm29eXl6CSz6TncsKo4rKH/6Rbf2zW/ippBaVP0Og7ohpNv3mjifPcwAQfhqTiYld/CSGgxnt8B1L0K1mwUitIselTCEctnmCspONtBSVnw261SwSBclGU/ZVrMcqy+T7fhAEbDKSB3eyCnmFbjULQ9nZI8xFuQlLxKS+qLwa4c4LS6a59XpdliULLaq5o5opdWboVrMAtDjFeLLgEBssk66zR3jmiUe3mqeiMZCIpzE5Zi8mvdWb8Zz4PvPem1uv15RSLUVRGezWZ2zY2YluNZ+PIfEerK0zMmMH3JxItO/7nufhhp2GtN31en1LhuvxNE1TFIV2JQFAlmWsTVmwXwjcPVSLqaoqUaXfu65jR0S003UdIcTzPN0D0Y3iaVVg4QdDerSr7P9sOErFxGW+7na7MxbV+7+ipvf87ajsTG846sTEPcHsxzOCjWBSoWbtAzAKdWLiemGf/UBzBST0ttiOoki7aTQHRWLinuApD7SWQs3Xor0Pp2koEhPn3Ex8oBUXar4Wpmm9fThNQ4WYuBixkAdaZaHma8FduUOki4mblUR98coKNV+L1ANV80W6mFjnUxktBrm5UqUvrNfrNxa5YuJyINkDLcpZVlCo+Vowx/Im5IqJsxbCH2jO7Akv1HwtJkRKzUSimDg/RsYDfeiQyQ4TYMLJLcgS0+HKWdIDLalQ87UYkkFlLLLExDnaUjdlDws1SwoTYDjgdqSIiVs5y36guQlU0hEDPD5wJ1IyLbkzQApOSHJ3lFGrBA823Y1weXKGQU18jzMbwo9lYjjgGMSLifNgoihSE9877Ock0L/BZk7HIHiaYzNa27Ysh5UVPRZSP/lOKKW+78dxzNZ37Ecm5elXZtM0JubejmAxsbz6scRxGIae5ymr7pDn+Xq9Hr/1MAwppdMVwDLNFfS2nz1iDR3nIRVFoXghvX9rELT1i9u6RyLeZzIhGCM8KcWED2U+4sVkQtaYkO9+s9lwGzWYCnc7UoKWevNZRSXy6k2ZmiOyjodrLHHMLQKmoKa3vT1IEqmuEsdio4u6UqZmisQUFLFhwyMRnpvA5UjhkctbkCgm9QkbMnITzDlZZT5yMy1VppLJ0y5XqFlqytSskX6gQFmSq9RQ0P7enJaTVbNAupjUOK2yg9RqUqbmjorKcQLX6jexXC77vpd9C9kpU7NHgWBlO61qko1kp0xZgKJaA1KdVmXJRocpUwpOVs0IdQVSuWYjrJv72VcbE6S4tBOpXJsyNf6IqKvPxDmtE/PB2R6Z+lCWypNVs0NpGcIoioIgEHhBLZkhhyerMKOXoVRMYhfwhmz/YZhgRHW1XbFVUMTauZNuvb9Dp3EkRqFaTMzLme7qMS4vLxWPn8GZ2K+++goAvvnmGy2DMQfVReWZuyqkQ8F33313dXX1/PnzzWajuE+B53lZllFKKaVJklRV9dlnn33yyScqx2AiutU8CXamihCiJceormt2d3SYGPMW0zAMu90ujmMAiONY5bKOpRKsVisMWo7MXkwMNtN5nqcgR3u73QZBQAjBw08clohpGIbdbsfC4lJjmKyPVBAEeLLgEHvExGAR6iAIhEeld7vdarWSLdZZY5uYhmFo25ZNQ2KroKCvfScWiokh0EFGX/tIrBXTMAx1XTOv/Gxzgr72SdgspmGao4O+9qlYLiZGlmUnyQJ97fNwQkzD3oT1888/3/4/f//9d/S1z+M1bfs4amHxzDiOf/zxR/bOYgHr9X/+z2IBAPD48WMWWVBQ7c4y1KXtGsLz58/v378PAIsFeB4UBYyaWSxgGF79B+RUnBPTyGIBdQ1JAm0LLOeAiQk5G1emuWuJIggCyHPd47AFpy3TMEDfQxhCXUMQoGWaitOWCQA8D9IUkkT3OKzAdTEBQJoCAL+yQ87A9WmO0TSwXAIATnOTQMsEABBFEMe6BzF/3LVMiHDQMiHCcFdMbPPk9neQk3BXTIhwUEyIMFBMiDBUHw83CnSSxOK0mLioCGprIjjNIcJAMSHCQDEhwsDtFEQYaJkQYaCYEGGgmBBhoJgQYaCYEGH8H6uSX1KFt0nvAAAAAElFTkSuQmCC "Click for a 3D rendering of (6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide")
(6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
UK: MDA Part I Class A Section 1(a) (6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Diethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 1 Diethylthiambutene
UK: MDA Part I Class A Section 1(a) Diethylthiambutene
UN: Narcotics Part 1 Section 1 Diethylthiambutene
US: CSA Schedule I Section b Subsection 19 Diethylthiambutene
Diethyltryptamine
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
N,N-Diethyltryptamine
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
2,3-Dihydro-1-benzofuran
UK: MDA Part II Class B Section 1(e) 2,3-Dihydro-1-benzofuran
1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
UK: MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
UK: MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
Dihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 11 Dihydrocodeine
UK: MDA Part II Class B Section 1(a) Dihydrocodeine
UN: Narcotics Part 1 Section 2 Dihydrocodeine and Part 2 Section 1 Dihydrocodeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
Dihydrocodeinone
CA: CDSA Schedule I Section 1 Subsection 15 Hydrocodone
UK: MDA Part I Class A Section 1(a) Hydrocodone
UN: Narcotics Part 1 Section 1 Hydrocodone
US: CSA Schedule II Section b Subsection 1 Item vi Hydrocodone
US: [revoked] CSA Schedule III Section e Subsection 1 Dihydrocodeinone and Dihydrocodeinone
⇒
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
Dihydrocodeinone enol acetate‡
Dihydrodeoxymorphine
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UK: MDA Part I Class A Section 1(a) Desomorphine
UN: Narcotics Part 1 Section 1 Desomorphine and Section 3 Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
Dihydroetorphine
UK: MDA Part I Class A Section 1(a) Dihydroetorphine
UN: Narcotics Part 1 Section 1 Dihydroetorphine
US: CSA Schedule II Section b Subsection 1 Item ii Dihydroetorphine
Dihydrohydroxymorphinone
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UK: MDA Part I Class A Section 1(a) Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
![3D rendering of [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone](data:image/png;base64,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 "Click for a 3D rendering of [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone")
[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
UK: MDA Part II Class B Section 1(c) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
![3D rendering of ((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone](data:image/png;base64,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 "Click for a 3D rendering of ((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone")
((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone
CA: CDSA Schedule II Section 2 Subsection 2 ((3R)-2,3-Dihydro-5-methyl-3(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone
⇒
PubChem: 5311501; ChemSpider: 4470978; Bluelight: WIN 55,212-2; Drugs Forum: WIN 55,212-2; Wikipedia: WIN_55,212-2((3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone
CA: [not controlled] CDSA Schedule II Section 2 ((3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone
Dihydromorphine
CA: CDSA Schedule I Section 1 Subsection 12 Dihydromorphine
UK: MDA Part I Class A Section 1(a) Dihydromorphine
UN: Narcotics Part 1 Section 1 Dihydromorphine
US: CSA Schedule I Section c Subsection 8 Dihydromorphine
Dihydromorphinone
CA: CDSA Schedule I Section 1 Subsection 17 Hydromorphone
UK: MDA Part I Class A Section 1(a) Hydromorphone
UN: Narcotics Part 1 Section 1 Hydromorphone
US: CSA Schedule II Section b Subsection 1 Item vii Hydromorphone
⇒
PubChem: 5284570; ChemSpider: 4447624; Drugs Forum: Hydromorphone; Erowid: Hydromorphone; Wikipedia: Hydromorphone
Dihydrotestosterone‡
CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
UK: MDA Part III Class C Section 1(b) Stanolone
US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
Δ1-Dihydrotestosterone
US: CSA Schedule III Section f Subsection 1 Item 18 Δ1-Dihydrotestosterone
4-Dihydrotestosterone
CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
UK: MDA Part III Class C Section 1(b) Stanolone
US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
3α,17β-Dihydroxy-5α-androstane
UK: MDA Part III Class C Section 1(b) 5α-Androstane-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 2 3α,17β-Dihydroxy-5α-androstane
3β,17β-Dihydroxy-5α-androstane
US: CSA Schedule III Section f Subsection 1 Item 1 3β,17β-Dihydroxy-5α-androstane
Dimenoxadol
CA: CDSA Schedule I Section 7 Subsection 1 Dimenoxadol
UK: MDA Part I Class A Section 1(a) Dimenoxadole
UN: Narcotics Part 1 Section 1 Dimenoxadol
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
Dimenoxadole
CA: CDSA Schedule I Section 7 Subsection 1 Dimenoxadol
UK: MDA Part I Class A Section 1(a) Dimenoxadole
UN: Narcotics Part 1 Section 1 Dimenoxadol
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
Dimepheptanol
CA: CDSA Schedule I Section 6 Subsection 6 Dimepheptanol
UK: MDA Part I Class A Section 1(a) Dimepheptanol
UN: Narcotics Part 1 Section 1 Dimepheptanol
US: CSA Schedule I Section b Subsection 22 Dimepheptanol
Dimethoxyamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
2,5-Dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
2,5-Dimethoxy-4-bromoamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
2,5-Dimethoxy-4-chloroamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 16 4-Chloro-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
UK: MDA Part I Class A Section 1(ba) 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
2,5-Dimethoxy-α,4-dimethylphenethylamine
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
2,5-Dimethoxy-4-ethylamphetamine
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 38 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
2,5-Dimethoxy-4-methylamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
2,5-Dimethoxy-4-methylphenethylamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-methylphenethylamine
US: CSA Schedule I Section d Subsection 39 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
UK: MDA Part I Class A Section 1(ba) 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
⇒
PubChem: 3017965; ChemSpider: 2285590; PiHKAL • info: DMCPA; Wikipedia: 4-Methyl-2,5-methoxyphenylcyclopropylamine
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-methylphenethylamine
US: CSA Schedule I Section d Subsection 39 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: MDA Part I Class A Section 1(f) 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
2,5-Dimethoxy-4-nitrophenethylamine
US: CSA Schedule I Section d Subsection 45 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
US: CSA Schedule I Section d Subsection 45 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
2,5-Dimethoxyphenethylamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 44 2-(2,5-Dimethoxyphenyl)ethanamine
2-(2,5-Dimethoxyphenyl)ethanamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 44 2-(2,5-Dimethoxyphenyl)ethanamine
2,5-Dimethoxy-4-propylphenethylamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-propylphenethylamine
US: CSA Schedule I Section d Subsection 46 2-(2,5-Dimethoxy-4-(n)-propyl-phenyl)ethanamine
2-(2,5-Dimethoxy-4-(n)-propyl-phenyl)ethanamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-propylphenethylamine
US: CSA Schedule I Section d Subsection 46 2-(2,5-Dimethoxy-4-(n)-propyl-phenyl)ethanamine
2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
EU: Substances Substances 2C-T-7
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
US: CSA Schedule I Section d Subsection 6 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
Dimethylaminodiphenylbutanonitrile
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol
UK: MDA Part II Class B Section 1(a) 2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol
![3D rendering of 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol](data:image/png;base64,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 "Click for a 3D rendering of 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol")
Dimethylamphetamine‡
US: CSA Schedule I Section f Subsection 8 N,N-Dimethylamphetamine
N,N-Dimethylamphetamine
US: CSA Schedule I Section f Subsection 8 N,N-Dimethylamphetamine
![3D rendering of 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone](data:image/png;base64,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 "Click for a 3D rendering of 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone")
2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone
UK: MDA Part I Class A Section 1(a) 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) CP 47,497
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) CP 47,497
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) CP 47,497
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
3-Dimethylheptyl-11-hydroxyhexahydrocannabinol
UK: MDA Part II Class B Section 1(c) 3-Dimethylheptyl-11-hydroxyhexahydrocannabinol
5-(1,1-Dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol
Dimethylheptylpyran‡
CA: CDSA Schedule II Section 2 Subsection 1 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I DMHP
3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
CA: CDSA Schedule II Section 2 Subsection 1 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I DMHP
2α,17α-Dimethyl-17β-hydroxy-5α-androstan-3-one
US: CSA Schedule III Section f Subsection 1 Item 32 Methasterone and Item 73 2α,17α-Dimethyl-17β-hydroxy-5α-androstan-3-one
⇒
PubChem: 237186; ChemSpider: 207079; Bluelight: Superdrol; Erowid: Steroids; Wikipedia: Methasterone
2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one
US: CSA Schedule III Section f Subsection 1 Item 74 2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one
N,N-Dimethyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 12 N,N-Dimethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
α,α-Dimethyl-3,4-methylenedioxyphenethylamine
UK: MDA Part I Class A Section 1(ba) α,α-Dimethyl-3,4-methylenedioxyphenethylamine
⇒
PubChem: 13020598; ChemSpider: 15204207; PiHKAL • info: MDPH; Wikipedia: Methylenedioxyphentermine
α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
UK: MDA Part I Class A Section 1(ba) α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
CA: CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 12 N,N-Dimethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
UK: MDA Part II Class B Section 1(c) CP 47,497-C8
US: CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
5-(1,1-Dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol
UK: MDA Part II Class B Section 1(c) CP 47,497-C8
US: CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
Dimethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 2 Dimethylthiambutene
UK: MDA Part I Class A Section 1(a) Dimethylthiambutene
UN: Narcotics Part 1 Section 1 Dimethylthiambutene
US: CSA Schedule I Section b Subsection 23 Dimethylthiambutene
Dimethyltryptamine
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
N,N-Dimethyltryptamine
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
3,6-Dinicotinoylmorphine
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
Dinicotinylmorphine
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
3,6-Dinicotinylmorphine
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
Dioxaphetyl butyrate
CA: CDSA Schedule I Section 7 Subsection 2 Dioxaphetyl butyrate
UK: MDA Part I Class A Section 1(a) Dioxaphetyl butyrate
UN: Narcotics Part 1 Section 1 Dioxaphetyl butyrate
US: CSA Schedule I Section b Subsection 24 Dioxaphetyl butyrate
Diphenoxylate
CA: CDSA Schedule I Section 3 Subsection 8 Diphenoxylate
UK: MDA Part I Class A Section 1(a) Diphenoxylate
UN: Narcotics Part 1 Section 1 Diphenoxylate and Part 2 Section 6 Diphenoxylate
US: CSA Schedule II Section c Subsection 8 Diphenoxylate and Schedule V Section c Subsection 4 Diphenoxylate
Diphenylmorpholinoisovaleric acid
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
Dipipanone
CA: CDSA Schedule I Section 5 Subsection 2 Dipipanone
UK: MDA Part I Class A Section 1(a) Dipipanone
UN: Narcotics Part 1 Section 1 Dipipanone
US: CSA Schedule I Section b Subsection 25 Dipipanone
DMA
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
DMCPA†
UK: MDA Part I Class A Section 1(ba) 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
⇒
PubChem: 3017965; ChemSpider: 2285590; PiHKAL • info: DMCPA; Wikipedia: 4-Methyl-2,5-methoxyphenylcyclopropylamine
DME†
UK: MDA Part I Class A Section 1(ba) 2-Amino-1-(3,4-dimethoxyphenyl)ethanol
DMHP
CA: CDSA Schedule II Section 2 Subsection 1 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I DMHP
DMT
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
DOB
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
DOC†
CA: CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 16 4-Chloro-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
DOET
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
DOM
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
Dronabinol
UN: Psychotropics Schedule II Dronabinol (delta-9-Tetrahydrocannabinol)
US: CSA Schedule III Section g Subsection 1 Dronabinol
Drostanolone
CA: CDSA Schedule IV Section 23 Subsection 11 Drostanolone
UK: MDA Part III Class C Section 1(b) Drostanolone
US: CSA Schedule III Section f Subsection 1 Item 20 Drostanolone
Drotebanol
CA: CDSA Schedule I Section 10 Subsection 2 Drotebanol
UK: MDA Part I Class A Section 1(a) Drotebanol
UN: Narcotics Part 1 Section 1 Drotebanol
US: CSA Schedule I Section c Subsection 9 Drotebanol
DXM†
CA: [not controlled] CDSA Schedule I Section 10 Subsection 10 Dextromethorphan
UK: MDA Part I Class A Section 2 Dextromethorphan
⇒
PubChem: 5360696; ChemSpider: 13109865; Bluelight: DXM; Drugs Forum: DXM; Wikipedia: DextromethorphanEAM-2201
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole
Eluxadoline
US: [pending] CSA Schedule IV Section g Subsection 3 Eluxadoline
Embutramide
US: CSA Schedule III Section c Subsection 5 Embutramide
Ephedrone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 75 2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol
Epitiostanol
CA: CDSA Schedule IV Section 23 Subsection 13 Epitiostanol
UK: MDA Part III Class C Section 1(b) Epitiostanol
Ergine‡
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
Ergocristine
US: CSA Listed Chemicals Section a Subsection 30 Ergocristine
Ergometrine
CA: CDSA Schedule VI Part 1 Subsection 5 Ergometrine
EU: Drug precursors Annex I Category 1 Ergometrine
UK: MDA Drug precursors Annex I Category 1 Ergometrine
UN: Precursors Table I Ergometrine
US: CSA Listed Chemicals Section a Subsection 4 Ergonovine
Ergonovine
CA: CDSA Schedule VI Part 1 Subsection 5 Ergometrine
EU: Drug precursors Annex I Category 1 Ergometrine
UK: MDA Drug precursors Annex I Category 1 Ergometrine
UN: Precursors Table I Ergometrine
US: CSA Listed Chemicals Section a Subsection 4 Ergonovine
Ergotamine
CA: CDSA Schedule VI Part 1 Subsection 6 Ergotamine
EU: Drug precursors Annex I Category 1 Ergotamine
UK: MDA Drug precursors Annex I Category 1 Ergotamine
UN: Precursors Table I Ergotamine
US: CSA Listed Chemicals Section a Subsection 5 Ergotamine
Estra-4,9,11-triene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 80 Estra-4,9,11-triene-3,17-dione
Ethchlorvynol
CA: CDSA Schedule IV Section 13 Ethchlorvynol
UK: MDA Part III Class C Section 1(a) Ethchlorvynol
UN: Psychotropics Schedule IV Ethchlorvynol
US: CSA Schedule IV Section c Subsection 19 Ethchlorvynol
Ether‡
CA: CDSA Schedule VI Part 2 Subsection 2 Ethyl ether
EU: Drug precursors Annex I Category 3 Ethyl ether
UK: MDA Drug precursors Annex I Category 3 Ethyl ether
UN: Precursors Table II Ethyl ether
US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
Ethinamate
CA: CDSA Schedule IV Section 14 Ethinamate
UK: MDA Part III Class C Section 1(a) Ethinamate
UN: Psychotropics Schedule IV Ethinamate
US: CSA Schedule IV Section c Subsection 20 Ethinamate
Ethoheptazine
CA: [not controlled] CDSA Schedule I Section 4 Subsection 2 Ethoheptazine
4-Ethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 16 4-Ethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 17 4-Ethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethoxyamphetamine
4-Ethoxy-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 9 4-Ethoxy-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 10 4-Ethoxy-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethoxy-2,5-dimethoxyamphetamine
Ethyl ether
CA: CDSA Schedule VI Part 2 Subsection 2 Ethyl ether
EU: Drug precursors Annex I Category 3 Ethyl ether
UK: MDA Drug precursors Annex I Category 3 Ethyl ether
UN: Precursors Table II Ethyl ether
US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
Ethyl loflazepate
CA: CDSA Schedule IV Section 18 Subsection 12 Ethyl loflazepate
UK: MDA Part III Class C Section 1(a) Ethyl loflazepate
UN: Psychotropics Schedule IV Ethyl loflazepate
US: CSA Schedule IV Section c Subsection 21 Ethyl loflazepate
N-Ethyl MDA
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
Ethylamine
US: CSA Listed Chemicals Section a Subsection 14 Ethylamine
Ethylamine analog of Phencyclidine
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
UK: MDA Part II Class B Section 1(d) Methoxetamine
UK: [revoked] MDA Temporary Class Drug Orders 2012 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
⇒
ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
Ethylamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
N-Ethylamphetamine
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
4-Ethyl-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
4-Ethyl-2,5-dimethoxyphenethylamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 38 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
Ethylestrenol
CA: CDSA Schedule IV Section 23 Subsection 14 Ethylestrenol
UK: MDA Part III Class C Section 1(b) Ethyloestrenol
US: CSA Schedule III Section f Subsection 1 Item 21 Ethylestrenol
13β-Ethyl-17β-hydroxygon-4-en-3-one
US: CSA Schedule III Section f Subsection 1 Item 25 13β-Ethyl-17β-hydroxygon-4-en-3-one
ETHYL-K†
UK: MDA Part I Class A Section 1(ba) 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
N-Ethyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
Ethylmethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 3 Ethylmethylthiambutene
UK: MDA Part I Class A Section 1(a) Ethylmethylthiambutene
UN: Narcotics Part 1 Section 1 Ethylmethylthiambutene
US: CSA Schedule I Section b Subsection 26 Ethylmethylthiambutene
Ethylmorphine
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UK: MDA Part II Class B Section 1(a) Ethylmorphine
UN: Narcotics Part 1 Section 2 Ethylmorphine and Part 2 Section 1 Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
3-Ethylmorphine
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UK: MDA Part II Class B Section 1(a) Ethylmorphine
UN: Narcotics Part 1 Section 2 Ethylmorphine and Part 2 Section 1 Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
Ethylnaphthidate
UK: MDA Temporary Class Drug Orders 2015 Ethylnaphthidate
Ethyloestrenol
CA: CDSA Schedule IV Section 23 Subsection 14 Ethylestrenol
UK: MDA Part III Class C Section 1(b) Ethyloestrenol
US: CSA Schedule III Section f Subsection 1 Item 21 Ethylestrenol
Ethylphenidate
UK: MDA Temporary Class Drug Orders 2015 Ethylphenidate
⇒
PubChem: 3080846; ChemSpider: 2338571; Drugs Forum: Ethylphenidate; Erowid: Ethylphenidate; Wikipedia: Ethylphenidate
N-Ethyl-3-piperidyl benzilate
US: CSA Schedule I Section d Subsection 27 N-Ethyl-3-piperidyl benzilate
4-Ethylthio-2,5-dimethoxyphenethylamine
EU: Substances Substances 2C-T-2
UK: MDA Part I Class A Section 1(c) 4-Ethylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 42 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
UK: MDA Part I Class A Section 1(ba) N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
EU: Substances Substances 2C-T-2
UK: MDA Part I Class A Section 1(c) 4-Ethylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 42 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
1-Ethynylcyclohexanolcarbamate
CA: CDSA Schedule IV Section 14 Ethinamate
UK: MDA Part III Class C Section 1(a) Ethinamate
UN: Psychotropics Schedule IV Ethinamate
US: CSA Schedule IV Section c Subsection 20 Ethinamate
Eticyclidine
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
Etilamfetamine
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
Etonitazene
CA: CDSA Schedule I Section 13 Subsection 2 Etonitazene
UK: MDA Part I Class A Section 1(a) Etonitazene
UN: Narcotics Part 1 Section 1 Etonitazene
US: CSA Schedule I Section b Subsection 27 Etonitazene
Etorphine hydrochloride
US: CSA Schedule II Section b Subsection 1 Item iv Etorphine hydrochloride
Etoxeridine
CA: CDSA Schedule I Section 3 Subsection 10 Etoxeridine
UK: MDA Part I Class A Section 1(a) Etoxeridine
UN: Narcotics Part 1 Section 1 Etoxeridine
US: CSA Schedule I Section b Subsection 28 Etoxeridine
Etryptamine
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Extracts and tinctures of cannabis
UN: Narcotics Part 1 Section 1 Extracts and tinctures of cannabis
US: [proposed] CSA Schedule I Section d Subsection 36 Marihuana extract
Ezogabine
US: CSA Schedule V Section e Subsection 1 Ezogabine
F-2†
UK: MDA Part I Class A Section 1(ba) 2-(5-Methoxy-2-methyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
F-22†
UK: MDA Part I Class A Section 1(ba) 2-(5-Methoxy-2,2-dimethyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
Fencamfamin
CA: CDSA Schedule IV Section 20 Fencamfamin
UK: MDA Part III Class C Section 1(a) Fencamfamin
UN: Psychotropics Schedule IV Fencamfamin
US: CSA Schedule IV Section f Subsection 3 Fencamfamin
Fencamfamine‡
CA: CDSA Schedule IV Section 20 Fencamfamin
UK: MDA Part III Class C Section 1(a) Fencamfamin
UN: Psychotropics Schedule IV Fencamfamin
US: CSA Schedule IV Section f Subsection 3 Fencamfamin
Fenethylline
CA: CDSA Schedule III Section 20 Fenetylline
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
US: CSA Schedule I Section f Subsection 4 Fenethylline
Fenetylline
CA: CDSA Schedule III Section 20 Fenetylline
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
US: CSA Schedule I Section f Subsection 4 Fenethylline
Fenfluramine
US: CSA Schedule IV Section d Subsection 1 Fenfluramine
Fenproporex
CA: CDSA Schedule IV Section 21 Fenproporex
UK: MDA Part III Class C Section 1(a) Fenproporex
UN: Psychotropics Schedule IV Fenproporex
US: CSA Schedule IV Section f Subsection 4 Fenproporex
Fentanyl [derivatives]
CA: CDSA Schedule I Section 16 Fentanyls
UK: MDA Part I Class A Section 1(d) Fentanyl [derivatives]
Fentanyls
CA: CDSA Schedule I Section 16 Fentanyls
UK: MDA Part I Class A Section 1(d) Fentanyl [derivatives]
FLEA†
UK: MDA Part I Class A Section 1(ba) N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
⇒
PubChem: 44350092; ChemSpider: 21106310; PiHKAL • info: FLEA; Wikipedia: Methylenedioxyhydroxymethamphetamine
Flephedrone
UK: MDA Part II Class B Section 1(aa) Flephedrone
US: CSA Schedule I Section h Subsection 17 4-Fluoro-N-methylcathinone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone
Fludiazepam
CA: CDSA Schedule IV Section 18 Subsection 13 Fludiazepam
UK: MDA Part III Class C Section 1(a) Fludiazepam
UN: Psychotropics Schedule IV Fludiazepam
US: CSA Schedule IV Section c Subsection 22 Fludiazepam
Flunitrazepam
CA: CDSA Schedule I Section 20 Flunitrazepam
CA: [revoked] CDSA Schedule III Section 25 Flunitrazepam
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
p-Fluorofentanyl
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
4-Fluoromethcathinone‡
UK: MDA Part II Class B Section 1(aa) Flephedrone
US: CSA Schedule I Section h Subsection 17 4-Fluoro-N-methylcathinone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone
3-Fluoro-N-methylcathinone
US: CSA Schedule I Section h Subsection 18 3-Fluoro-N-methylcathinone
4-Fluoro-N-methylcathinone
UK: MDA Part II Class B Section 1(aa) Flephedrone
US: CSA Schedule I Section h Subsection 17 4-Fluoro-N-methylcathinone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole
methanone](data:image/png;base64,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 "Click for a 3D rendering of [1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone")
[1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
US: CSA Schedule I Section h Subsection 23 [1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) AM-2201
US: CSA Schedule I Section g Subsection 11 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid
CA: CDSA Schedule II Section 2 Subsection 7 1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 8 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Fluoxymesterone
CA: CDSA Schedule IV Section 23 Subsection 16 Fluoxymesterone
UK: MDA Part III Class C Section 1(b) Fluoxymesterone
US: CSA Schedule III Section f Subsection 1 Item 22 Fluoxymesterone
Flurazepam
CA: CDSA Schedule IV Section 18 Subsection 15 Flurazepam
UK: MDA Part III Class C Section 1(a) Flurazepam
UN: Psychotropics Schedule IV Flurazepam
US: CSA Schedule IV Section c Subsection 24 Flurazepam
Formebolone
CA: CDSA Schedule IV Section 23 Subsection 17 Formebolone
UK: MDA Part III Class C Section 1(b) Formebolone
US: CSA Schedule III Section f Subsection 1 Item 23 Formebolone
Fospropofol
US: CSA Schedule IV Section c Subsection 25 Fospropofol
Foxy§
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-diisopropyltryptamine
US: CSA Schedule I Section d Subsection 20 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
Fungus
UK: MDA Part I Class A Section 1(a) Fungus
![3D rendering of [3,2-c]-Furazan-5α-androstan-17β-ol](data:image/png;base64,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 "Click for a 3D rendering of [3,2-c]-Furazan-5α-androstan-17β-ol")
[3,2-c]-Furazan-5α-androstan-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 76 [3,2-c]-Furazan-5α-androstan-17β-ol
Furethidine
CA: CDSA Schedule I Section 3 Subsection 11 Furethidine
UK: MDA Part I Class A Section 1(a) Furethidine
UN: Narcotics Part 1 Section 1 Furethidine
US: CSA Schedule I Section b Subsection 29 Furethidine
G-3†
UK: MDA Part I Class A Section 1(ba) 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
G-4†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
G-5†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
Gamma-butyrolactone
CA: CDSA Schedule VI Part 1 Subsection 18 Gamma-butyrolactone
UK: MDA Part III Class C Section 1(a) Gamma-butyrolactone
US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
Gamma-hydroxybutyric acid
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
GBL†
CA: CDSA Schedule VI Part 1 Subsection 18 Gamma-butyrolactone
UK: MDA Part III Class C Section 1(a) Gamma-butyrolactone
US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
Gestrinone
UK: MDA Part III Class C Section 1(b) Gestrinone
GHB
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Glutethimide
CA: CDSA Schedule IV Section 11 Glutethimide
UK: MDA Part II Class B Section 1(a) Glutethimide
UN: Psychotropics Schedule III Glutethimide
US: CSA Schedule II Section e Subsection 2 Glutethimide
G-N†
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
Granulated opium
US: CSA Schedule II Section b Subsection 1 Item v Granulated opium
Haloxazolam
CA: CDSA Schedule IV Section 18 Subsection 17 Haloxazolam
UK: MDA Part III Class C Section 1(a) Haloxazolam
UN: Psychotropics Schedule IV Haloxazolam
US: CSA Schedule IV Section c Subsection 27 Haloxazolam
Harmalol
CA: CDSA Schedule III Section 10 Harmalol
HDMP-28
UK: MDA Temporary Class Drug Orders 2015 Methylnaphthidate
Heptabarbital
CA: CDSA Schedule IV Section 1 Subsection 13 Heptabarbital
Heroin
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
US: CSA Schedule I Section c Subsection 11 Heroin
![3D rendering of (6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of (6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
(6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I (6aR,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Hexobarbital
CA: CDSA Schedule IV Section 1 Subsection 15 Hexobarbital
1-Hexyl-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Hexyl-3-(1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 5 1-Hexyl-3-(1-naphthoyl)indole
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one
US: CSA Schedule III Section f Subsection 1 Item 81 18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one
HOT-17†
UK: MDA Part I Class A Section 1(ba) N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
HOT-2†
UK: MDA Part I Class A Section 1(ba) N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
Hydriodic acid
CA: CDSA Schedule VI Part 1 Subsection 23 Hydriodic acid
US: CSA Listed Chemicals Section a Subsection 21 Hydriodic acid
Hydrochloric acid
CA: CDSA Schedule VI Part 2 Subsection 3 Hydrochloric acid
EU: Drug precursors Annex I Category 3 Hydrochloric acid
UK: MDA Drug precursors Annex I Category 3 Hydrochloric acid
UN: Precursors Table II Hydrochloric acid
US: CSA Listed Chemicals Section b Subsection 8 Hydrochloric acid
Hydrocodone
CA: CDSA Schedule I Section 1 Subsection 15 Hydrocodone
UK: MDA Part I Class A Section 1(a) Hydrocodone
UN: Narcotics Part 1 Section 1 Hydrocodone
US: CSA Schedule II Section b Subsection 1 Item vi Hydrocodone
US: [revoked] CSA Schedule III Section e Subsection 1 Dihydrocodeinone and Dihydrocodeinone
⇒
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
Hydrogen chloride
CA: CDSA Schedule VI Part 2 Subsection 3 Hydrochloric acid
EU: Drug precursors Annex I Category 3 Hydrochloric acid
UK: MDA Drug precursors Annex I Category 3 Hydrochloric acid
UN: Precursors Table II Hydrochloric acid
US: CSA Listed Chemicals Section b Subsection 8 Hydrochloric acid
Hydromorphinol
CA: CDSA Schedule I Section 1 Subsection 16 Hydromorphinol
UK: MDA Part I Class A Section 1(a) Hydromorphinol
UN: Narcotics Part 1 Section 1 Hydromorphinol
US: CSA Schedule I Section c Subsection 12 Hydromorphinol
Hydromorphone
CA: CDSA Schedule I Section 1 Subsection 17 Hydromorphone
UK: MDA Part I Class A Section 1(a) Hydromorphone
UN: Narcotics Part 1 Section 1 Hydromorphone
US: CSA Schedule II Section b Subsection 1 Item vii Hydromorphone
⇒
PubChem: 5284570; ChemSpider: 4447624; Drugs Forum: Hydromorphone; Erowid: Hydromorphone; Wikipedia: Hydromorphone
N-Hydroxy MDA
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
![3D rendering of 17β-Hydroxy-androstano[2,3-d]isoxazole](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAOIAAACdCAIAAAAmBjOUAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC43MQM/aDQAAAx5SURBVHic7Z2/j6PGG8bHX91dl2K2T4OV1FGwlCJStAVbRkoK3KeB+w+guR43uRradFyxShcJF2nS4Ui5IkoiQXlFCmgS6TpSvN9MWPBifgwDs34+Op3WLOZlvc++884w88ymqioGwLr539I3AMBlIFOgAZAp0ADIFGgAZAo0ADIFGgCZAg2ATIEGQKZAAyBToAGQKdAAyBRoAGQKNAAyBRoAmQINgEyBBkCmoB9lyVyX3dywzYbd3DDXZWX533c3m+b57SMTgExBD8qSbbeMc5amrKpYmjLO2Xb7QKlzssEiE3AZ12WcsyB4cND3WVmyMGSMsc2GNYTUPjIByBT04OaGpSkzjAcH85ztdqwoGINMwRp4THPi+NlKVJ60UJuCHnDO8rx5MM8Z5/+9rKoH/6QCmYIe2DaLoubBKGK2rSb+MzVhgN4EAdtuGWPMcZhhsDxnUcSiiGWZmvjIpqAHnLMsY2XJdju22bDdjpUly7IHjf6coAsFNACNPhjA8XgUX1uWpSwusulVUJbl6XSqHzFNkw9vsje1gSeVykE2vRbu7u7qL5MkGZEOLcuihKoylTJ0oa6EEYlzVUCm14Lx8FHnuHRommbjCzVAptdCQ6Z6AZleC/V2f3QuFBdRLHrI9FqoC2t0qSr0DZmC2ZkuMsV9Msj0Wqj3maZnU3ShwOyMlulSA1sY3r8W6vlvSi7knCtOpQzZ9HqQlQjVa5RBpnpxPB7v7u5ubm4Oh8OIt4ue08RHncim4Dx5nruuS8/lHcfxfX+73dbnK/VByigSsik4Q1mWvu/vdrvj8RiGYZIkQRBkWWYYxt3d3X6/z9urlB6B2v3pOkM2BQ+Iomi320VR5DhOlmWO49BxwzCSJEmS5HQ6bbdb3/fLHs4OlE0nFqmGYajv70OmK4XKUNd1LcvKsixoWDkwxhgT34qiaLvdRu1VdeeY0vSXZfnbb789f/589BVGUoGVIbKmZVlpmvZ5S1EUnucxxkzTTJLksdOSJGGMeZ434paCIBAdL855URRDLzIFyHRFkNo454ZhxHE89O1ZlpGSqEJon0AyDYKg/wWDIKBKlHPuOE4cx0VRGIZhWdbQ25sCZLoWwjCksm9EtqsTx7G4TjvnMcY60i2RpmlbnY0TBsl9OpDp8oj1Ho7jyGpMRVYOw7B+vEOmaZp6nkeVq2EYnud1lBxUY/SsSaYDmS7JiDK0P0VRiIsLaZqm2ThtkDrrWJZlGIaaIhUyXYaJZWh/0jStp2pRU8Zx7DgOqdM0zf7qFGRZRiXBDHfdBDJdgHr5qCaiKHxvb28dxxHj/PSkYPRl4zhmjM36Z0ZApgvAGLNtW/GYTn3QaqI661CbIOtqjwE7iQXYbDbjlsmvMHRZljTTgLr/M4GnUGASnPMwDPM8931/viiQKZgK9cAOh8PQGVv9gUyBBDzPs217v9/3mQEzAsgUyCEMQ86567pzXBwyBXKgIvXNmzfjVhZ0A5kCaViW5Xme7/sNk8rpQKbasGltatM+sjg0Z8V1XblFKmQKJBPHcZ7ncpt+yBRIhqZlHQ6HN2/eyLomZArkY9u24ziu6/ZfTtgNXE+GEUVRI0nQlHg1rLAYfQzHcaIoyvNcyqpryHQYeZ4vtZsHa+3KsGbVuq5rmqaszwcyHYbWnsvK8H0/z3OJ7QxkOoyGTBexAFk5NMIfhqHEDwddqGHoviXI3JCJkOM4wvlCCpDpMBoZQmUN0J4ZvMK5wq7rcs7Pml9MATKdhOJSdbfbbf5FZdye+L5/PB7jOJbe5kCmg6n3XhXLdM0lx/F4PBwOYoG/XCDTSSiWqQi3tgGHsiz3+71t27TcSjqQ6WBEtlCf25balukiVJKGYTjT9TEgNR71o1HrbPTp8X2SJPPd3pVm07IsR6/dmZjJaIbbuHluE/e7oaByJ4OeTiff9z3Pm/eB3KzLq9cJeSvQj/+YeV0H4uHKCDMIWtUu3j50qf6U0EEQiNBnDcxGoMyd77pk2nCq6Tav67jICK00YpFoqJ4b9CNQ6EHvSpKE/iwpdN2slHNu23YYhuO8LchARYEvxrXI9KzvF/GYeV0HpJWe2ahhOypS2v39fR/v3LOhe54vQtu2Lb4WwiqKIgxD27bpmkP1Sh0mBc481YIyLYpCmTvNRSHWRdzH8aunVs6aOKdpSrb59LKhpIuhqSodFzrLsiRJ2j/gWb1230yapio9sJaRaZZlL168GPEXPJRBzXp/n1E6rfsXOahZb7TLF0N3X43WItNDy4uhG5BT30UvNNM02x6U87GMTE3T/OSTT16/fj26xblIvQwd1Enq49rcrZVuzSX/0v6WUHaHvOgT6whN6bY79GNvr9OhVzX2ZnUWkCn9kKLpmVghtem5X8LFK3SYj9J328cvtuB1P7CzWhQ3T1vqnA1tGMbZ0PQZ0vYm7RPqsz8HfSxxHAufXtM0qToa2vObiGqZduxSIEWvo3vQbTp+8TRM2Lj5bnnpEroD4SutrCQVKJVpURQ0AiKOUG+xfVq9xemp1/7l3SDONqNxHNe1MqUWHBqaCui5Q68NpTK1bbvu1t6nt9jWa7tFG9pZHkFDDUmS0G1314JtiqIQBWLPW+0IPWhjiRGh14M6mdJUWdEqFUUxqLd4tqJX1t5VD9vW77777uXLl9214FnqE4jqrUr/0Pf39y9fvhyxsUQ9tOJdnaajSKbUdagnztG9xbpeX7x4obi9E1UjiUbN4PbioRdHhUzbiZO2FpjYy3n16hVjTLGDPeF5nspRw5WEXhAVE/kOh0Oe52IsZsqqrsPhcDqdSOVffPEFW25u27i4eZ7XjUDGzSoaF/p0OolpWZxzvdbEzi5TWg5LT4PoyH6/Nwxj3Kqusixn8iNWg+u69dmDaZqqkQtt5FCXaX12wfqZV6YicYqiShgNaPQZSUSlk08dmm6ySGgpzDst2nXdeuKkVV1UXc0aFzwxZsymP/74o2VZX3/9NSXOuVd1acEff/zx119/iZcfffTRBx98oCb0zz//XH+pMvR0ZpTp7e3t7e2teLnf72dd1aUFH3/88VKhP/3006VCT0dOo7/ZsN2ONfo2dceD+YwGwDUgszZ9bJu10+mEkpQtap6vhW9/B9JkGoYsilgUNY+/f/9+v99bliXdVwhcD9JkaposCJjvs8by2h9++KEsSxqQB2AcMht9z2OmyVz3QZH6+++/oyQFE5E8bhrHLM8fFKmfffbZIjtyr5PNQ64k9HQkD0hxzsKQ7fdMOIPUx6RAtZx5/oKhpyP/KZRtM897tNcPwAhmeVhKRSoAspDT6DfMtTlntRWUAExlxqknb9++/emnn/7+++/5QuhFtZx5/oKhpTCjTD/88MMvv/zym2++mS8EuBJmlCnnPI5jmhY9XxRwDcw739SyLM/zaGXIrIHA02Z2t+ggCAzDcF1X68UhYFlUmJrHcZznuZSm3/M8MWO1Pr8YPHHULGClqSdSlpY3rKYGuTlIQbiD97QbkQg5oPT3oXgyqHM9+fbbb7/66qt3796Ne/tZI7T7+/tB3jgTqVvx9PGXnCn0ItYEy7J2U/M+Nn0K7L7qFnnff/+9ZVmWZb1+/VqBNdBFR8hrYKUyHWoiOd3T9OKVhRbpiOd55N80n4xUOmStHOUyLYrKcSrOK8YqzivHqWrim2hxKt2ar3+elt4o93GOvh7UyrQoKs4rz6tIQ1lWeV7FOSn1l19+YbUti0b/sqUYnY6TnZTyYyajVq1RK1PHqdodDs+rHKeqql9//VWiy9xo2+gsy7ptGcMwpNrUtu22jKaUHwqMWjVFrUw5r9qffpZV53zsp9OxF9Rj53db7hPk7e15XkfKHCq4+Wrrp4FamT42TDvn8G3PLU3mGGDq2XxL3C/gqfKUs2mdjg2iGjtESg/doUKUoT1ZUW2qgEabPrQqqP7d5UI8w+v/rkYglKGDWFFPX9Ut/F8xpmkO3aqUELs5Di0iRdqm/1GG9mdd46bKSJKEvAHVN7W0WQ/K0EFsKq0WG4DrRIX3/lPidDr5tcXdtPXPgvdzJUCmwzAMo+4reOUeg8pAow80QMXsfQAmgkZ/GG/fvv3zzz/Fy2fPnn3++efPnz9f8JauATT6QAPQ6A9Dd3dwTYFMgQZApkADIFOgAejpDwbFqHog08FUOruDawoafaABkCnQAMgUaACeQgENQDYFGgCZAg2ATIEGQKZAAyBToAGQKdAAyBRoAGQKNAAyBRoAmQINgEyBBkCmQAMgU6ABkCnQAMgUaABkCjTgH7aEW8JGD/OqAAAAAElFTkSuQmCC "Click for a 3D rendering of 17β-Hydroxy-androstano[2,3-d]isoxazole")
17β-Hydroxy-androstano[2,3-d]isoxazole
US: CSA Schedule III Section f Subsection 1 Item 85 17β-Hydroxy-androstano[2,3-d]isoxazole
![3D rendering of 17β-Hydroxy-androstano[3,2-c]isoxazole](data:image/png;base64,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 "Click for a 3D rendering of 17β-Hydroxy-androstano[3,2-c]isoxazole")
17β-Hydroxy-androstano[3,2-c]isoxazole
US: CSA Schedule III Section f Subsection 1 Item 86 17β-Hydroxy-androstano[3,2-c]isoxazole
17-Hydroxyandrostan-3-one
UK: MDA Part III Class C Section 1(c) 17-Hydroxyandrostan-3-one
3-Hydroxy-5α-androstan-17-one
UK: MDA Part III Class C Section 1(b) 3-Hydroxy-5α-androstan-17-one
![3D rendering of 4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol](data:image/png;base64,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 "Click for a 3D rendering of 4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol")
4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 87 4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol
4-Hydroxybutanoic acid
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
4-Hydroxybutyrate
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
γ-Hydroxybutyric acid
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
4-Hydroxy-n-butyric acid
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
2-(3-Hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) 2-(3-Hydroxycyclohexyl)phenol
US: CSA Schedule I Section i Item i 2-(3-Hydroxycyclohexyl)phenol
14-Hydroxydihydromorphine
CA: CDSA Schedule I Section 1 Subsection 16 Hydromorphinol
UK: MDA Part I Class A Section 1(a) Hydromorphinol
UN: Narcotics Part 1 Section 1 Hydromorphinol
US: CSA Schedule I Section c Subsection 12 Hydromorphinol
14-Hydroxydihydromorphinone
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UK: MDA Part I Class A Section 1(a) Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
17-Hydroxyestran-3-one
UK: MDA Part III Class C Section 1(c) 17-Hydroxyestran-3-one
3β-Hydroxy-estra-4,9,11-trien-17-one
US: CSA Schedule III Section f Subsection 1 Item 77 3β-Hydroxy-estra-4,9,11-trien-17-one
N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: CDSA Schedule I Section 19 Subsection 19 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 20 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
β-Hydroxyfentanyl
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
![3D rendering of 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol](data:image/png;base64,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 "Click for a 3D rendering of 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol")
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
UK: MDA Part II Class B Section 1(c) 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
N-Hydroxy-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
β-Hydroxy-3-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
![3D rendering of [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate](data:image/png;base64,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 "Click for a 3D rendering of [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate")
[9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
UK: MDA Part II Class B Section 1(c) [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
4-Hydroxy-19-nortestosterone
CA: CDSA Schedule IV Section 23 Subsection 15 4-Hydroxy-19-nortestosterone
US: CSA Schedule III Section f Subsection 1 Item 27 4-Hydroxy-19-nortestosterone
Hydroxypethidine
CA: CDSA Schedule I Section 3 Subsection 12 Hydroxypethidine
UK: [revoked] MDA Part I Class A Section 1(a) Hydroxypethidine
UN: Narcotics Part 1 Section 1 Hydroxypethidine
US: CSA Schedule I Section b Subsection 30 Hydroxypethidine
N-Hydroxy-tenamphetamine
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
N-Hydroxytenamphetamine
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
4-Hydroxytestosterone
US: CSA Schedule III Section f Subsection 1 Item 26 4-Hydroxytestosterone
Hypophosphorous acid
CA: CDSA Schedule VI Part 1 Subsection 22 Hypophosphorous acid
US: CSA Listed Chemicals Section a Subsection 27 Hypophosphorous acid
IDNNA†
UK: MDA Part I Class A Section 1(ba) 4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
Indane
UK: MDA Part II Class B Section 1(e) Indane
1H-Indene
UK: MDA Part II Class B Section 1(e) 1H-Indene
1H-Indole
UK: MDA Part II Class B Section 1(e) 1H-Indole
Indoline
UK: MDA Part II Class B Section 1(e) Indoline
1-(1H-Indol-5-yl)-1-methylethylamine
EU: Substances Substances 5-(2-Aminopropyl)indole
UK: MDA Part II Class B Section 1(e) 1-(1H-Indol-5-yl)-1-methylethylamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(1H-Indol-5-yl)-1-methylethylamine
⇒
PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
1-(1H-Indol-6-yl)-1-methylethylamine
UK: MDA Part II Class B Section 1(e) 1-(1H-Indol-6-yl)-1-methylethylamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 1-(1H-Indol-6-yl)-1-methylethylamine
1H-Indol-3-yl-(1-naphthyl)methane
UK: MDA Part II Class B Section 1(c) 1H-Indol-3-yl-(1-naphthyl)methane
US: CSA Schedule I Section ii Item ii 3-(1-Naphthylmethane)indole
1H-Indol-3-yl-(2-naphthyl)methane
UK: MDA Part II Class B Section 1(c) 1H-Indol-3-yl-(2-naphthyl)methane
4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
UK: MDA Part I Class A Section 1(ba) 4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
4-Iodo-2,5-dimethoxyphenethylamine
EU: Substances Substances 2C-I
UK: MDA Part I Class A Section 1(c) 4-Iodo-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 41 2-(4-Iodo-2,5-dimethoxy-phenyl)ethanamine
2-(4-Iodo-2,5-dimethoxy-phenyl)ethanamine
EU: Substances Substances 2C-I
UK: MDA Part I Class A Section 1(c) 4-Iodo-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 41 2-(4-Iodo-2,5-dimethoxy-phenyl)ethanamine
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
![3D rendering of [123I]Ioflupane](data:image/png;base64,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 "Click for a 3D rendering of [123I]Ioflupane")
[123I]Ioflupane
US: [not controlled] CSA Schedule II Section b Subsection 4 Item ii [123I]Ioflupane
IPP
UK: MDA Temporary Class Drug Orders 2015 Isopropylphenidate
IPPD
UK: MDA Temporary Class Drug Orders 2015 Isopropylphenidate
Isomethadone
CA: CDSA Schedule I Section 5 Subsection 3 Isomethadone
UK: MDA Part I Class A Section 1(a) Isomethadone
UN: Narcotics Part 1 Section 1 Isomethadone
US: CSA Schedule II Section c Subsection 10 Isomethadone
Isopropylphenidate
UK: MDA Temporary Class Drug Orders 2015 Isopropylphenidate
4-Isopropylthio-2,5-dimethoxyphenethylamine
UK: MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine and 4-Isopropylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 43 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
UK: MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine and 4-Isopropylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 43 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
Isosafrole
CA: CDSA Schedule VI Part 1 Subsection 7 Isosafrole
EU: Drug precursors Annex I Category 1 Isosafrole
UK: MDA Drug precursors Annex I Category 1 Isosafrole
UN: Precursors Table I Isosafrole
US: CSA Listed Chemicals Section a Subsection 16 Isosafrole
JWH-018
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-018
US: CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
JWH-019
CA: CDSA Schedule II Section 2 Subsection 2 1-Hexyl-3-(1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 5 1-Hexyl-3-(1-naphthoyl)indole
JWH-022
CA: CDSA Schedule II Section 2 Subsection 2 1-(4-Pentenyl)-3-(1-naphthoyl)indole
JWH-073
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-073
US: CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
⇒
PubChem: 10471670; ChemSpider: 8647081; Bluelight: JWH-073; Erowid: Spice Product; Wikipedia: JWH-073JWH-080
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
JWH-081
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-081
US: CSA Schedule I Section g Subsection 8 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
JWH-122
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-122
US: CSA Schedule I Section g Subsection 9 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
JWH-200
CA: CDSA Schedule II Section 2 Subsection 2 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-200
US: CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
JWH-203
US: CSA Schedule I Section g Subsection 15 1-Pentyl-3-(2-chlorophenylacetyl)indole
JWH-210
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole
JWH-250
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(2-methoxyphenylacetyl)indole
UK: MDA Part II Class B Section 1(c) JWH-250
US: CSA Schedule I Section g Subsection 7 1-Pentyl-3-(2-methoxyphenylacetyl)indole
JWH-251
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(2-methylphenylacetyl)indole
JWH-267
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(2-methoxy-1-naphthoyl)indole
JWH-302
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(3-methoxyphenylacetyl)indole
JWH-307
CA: CDSA Schedule II Section 2 Subsection 3 1-Pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole
Ketobemidone
CA: CDSA Schedule I Section 3 Subsection 13 Ketobemidone
UK: MDA Part I Class A Section 1(a) Ketobemidone
UN: Narcotics Part 1 Section 1 Ketobemidone and Section 3 Ketobemidone
US: CSA Schedule I Section b Subsection 31 Ketobemidone
Khat
CA: CDSA Schedule IV Section 19 Catha edulis
UK: MDA Part III Class C Section 1(a) Khat
Klonopin®
CA: CDSA Schedule IV Section 18 Subsection 6 Clonazepam
UK: MDA Part III Class C Section 1(a) Clonazepam
UN: Psychotropics Schedule IV Clonazepam
US: CSA Schedule IV Section c Subsection 11 Clonazepam
⇒
PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
LA-111†
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
LAAM
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
Lacosamide
US: CSA Schedule V Section e Subsection 2 Lacosamide
LBJ
CA: CDSA Schedule III Section 8 N-Methyl-3-piperidyl benzilate (LBJ)
US: CSA Schedule I Section d Subsection 28 N-Methyl-3-piperidyl benzilate
Lectopam®
CA: CDSA Schedule IV Section 18 Subsection 2 Bromazepam
UK: MDA Part III Class C Section 1(a) Bromazepam
UN: Psychotropics Schedule IV Bromazepam
US: CSA Schedule IV Section c Subsection 4 Bromazepam
⇒
PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
Lefetamine
CA: CDSA Schedule III Section 29 Lefetamine
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
Levallorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 12 Levallorphan
Levamfetamine
UN: Psychotropics Schedule II Levamfetamine (Levamphetamine)
Levamphetamine
UN: Psychotropics Schedule II Levamfetamine (Levamphetamine)
Levargorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 13 Levargorphan
Levo-alphacetylmethadol
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
Levomethadyl acetate
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
Levomethamphetamine
UN: Psychotropics Schedule II Levomethamphetamine
Levomethorphan
CA: CDSA Schedule I Section 10 Subsection 3 Levomethorphan
UK: MDA Part I Class A Section 1(a) Levomethorphan
UN: Narcotics Part 1 Section 1 Levomethorphan
US: CSA Schedule II Section c Subsection 12 Levomethorphan
⇒
PubChem: 5362449; ChemSpider: 4642423; Bluelight: Levomethorphan; Drugs Forum: Levomethorphan; Wikipedia: Levomethorphan
Levomoramide
CA: CDSA Schedule I Section 9 Subsection 3 Levomoramide
UK: MDA Part I Class A Section 1(a) Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
Levonantradol‡
UK: MDA Part II Class B Section 1(c) [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
Levophenacylmorphan
CA: CDSA Schedule I Section 10 Subsection 5 Levophenacylmorphan
UK: MDA Part I Class A Section 1(a) Levophenacylmorphan
UN: Narcotics Part 1 Section 1 Levophenacylmorphan
US: CSA Schedule I Section b Subsection 33 Levophenacylmorphan
Levorphanol
CA: CDSA Schedule I Section 10 Subsection 4 Levorphanol
UK: MDA Part I Class A Section 1(a) Levorphanol
UN: Narcotics Part 1 Section 1 Levorphanol
US: CSA Schedule II Section c Subsection 13 Levorphanol
⇒
PubChem: 5359272; ChemSpider: 16736212; Bluelight: Levorphanol ; Drugs Forum: Levorphanol ; Erowid: Levorphanol Synthesis; Wikipedia: Levorphanol
Librium®
CA: CDSA Schedule IV Section 18 Subsection 4 Chlordiazepoxide
UK: MDA Part III Class C Section 1(a) Chlordiazepoxide
UN: Psychotropics Schedule IV Chlordiazepoxide
US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
⇒
PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
Lisdexamfetamine
UK: MDA Part II Class B Section 1(a) Lisdexamfetamine
US: CSA Schedule II Section d Subsection 5 Lisdexamfetamine
Lofentanil
UK: MDA Part I Class A Section 1(a) Lofentanil
Lophophora
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
US: CSA Schedule I Section d Subsection 26 Peyote
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: PeyoteLophophora williamsii†
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
US: CSA Schedule I Section d Subsection 26 Peyote
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
Loprazolam
CA: CDSA Schedule IV Section 18 Subsection 19 Loprazolam
UK: MDA Part III Class C Section 1(a) Loprazolam
UN: Psychotropics Schedule IV Loprazolam
US: CSA Schedule IV Section c Subsection 29 Loprazolam
Lorcaserin
US: CSA Schedule IV Section e Subsection 1 Lorcaserin
⇒
PubChem: 11658860; ChemSpider: 9833595; Bluelight: Lorcaserin; Erowid: Lorcaserin; Wikipedia: Lorcaserin
Lormetazepam
CA: CDSA Schedule IV Section 18 Subsection 21 Lormetazepam
UK: MDA Part III Class C Section 1(a) Lormetazepam
UN: Psychotropics Schedule IV Lormetazepam
US: CSA Schedule IV Section c Subsection 31 Lormetazepam
LSA†
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
LSD
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
LSD-25
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
LSZ
UK: MDA Part I Class A Section 1(a) 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone
Lysergamide
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
Lysergic acid
CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
UN: Precursors Table I Lysergic acid
US: CSA Schedule III Section c Subsection 8 Lysergic acid
Lysergic acid amide
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
Lysergic acid diethylamide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
Lysergide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
(+)-Lysergide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
Madol
UK: MDA Part III Class C Section 1(b) Desoxymethyltestosterone
US: CSA Schedule III Section f Subsection 1 Item 17 Desoxymethyltestosterone
Magic mushrooms§
UK: MDA Part I Class A Section 1(a) Fungus
Mappine
UK: MDA Part I Class A Section 1(a) Bufotenine
US: CSA Schedule I Section d Subsection 17 Bufotenine
Marihuana extract
UN: Narcotics Part 1 Section 1 Extracts and tinctures of cannabis
US: [proposed] CSA Schedule I Section d Subsection 36 Marihuana extract
MDA
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
MDAL†
UK: MDA Part I Class A Section 1(ba) Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
MDBZ†
UK: MDA Part I Class A Section 1(ba) Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
PubChem: 20507314; ChemSpider: 15110233; PiHKAL • info: MDBZ; Wikipedia: Methylenedioxybenzylamphetamine
MDCPM†
UK: MDA Part I Class A Section 1(ba) Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
MDDM†
CA: CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 12 N,N-Dimethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
MDE
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
MDEA†
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
MDHOET†
CA: CDSA Schedule I Section 19 Subsection 19 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 20 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
MDMA
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
MDMEO†
UK: MDA Part I Class A Section 1(ba) O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
MDMEOET†
UK: MDA Part I Class A Section 1(ba) 2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
MDMP†
UK: MDA Part I Class A Section 1(ba) α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
MDOH†
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
MDPH†
UK: MDA Part I Class A Section 1(ba) α,α-Dimethyl-3,4-methylenedioxyphenethylamine
⇒
PubChem: 13020598; ChemSpider: 15204207; PiHKAL • info: MDPH; Wikipedia: Methylenedioxyphentermine
MDPL†
UK: MDA Part I Class A Section 1(ba) α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
MDPR†
CA: CDSA Schedule I Section 19 Subsection 18 N-Propyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 19 N-Propyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Propyl-3,4-methylenedioxyamphetamine
MDPV
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
US: CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
Mebolazine
CA: CDSA Schedule IV Section 23 Subsection 19 Mebolazine
UK: MDA Part III Class C Section 1(b) Mebolazine
Mebutamate
US: CSA Schedule IV Section c Subsection 32 Mebutamate
Mecloqualone
CA: CDSA Schedule III Section 4 Mecloqualone
UK: MDA Part II Class B Section 1(a) Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
US: CSA Schedule I Section e Subsection 2 Mecloqualone
MEK
CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
UN: Precursors Table II Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
MEM†
CA: CDSA Schedule I Section 19 Subsection 9 4-Ethoxy-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 10 4-Ethoxy-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethoxy-2,5-dimethoxyamphetamine
Mephedrone
EU: Substances Substances 4-Methylmethcathinone
UK: MDA Part II Class B Section 1(aa) 4-Methylmethcathinone; Mephedrone
US: CSA Schedule I Section d Subsection 36 4-Methylmethcathinone
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
Mephentermine
UK: MDA Part III Class C Section 1(a) Mephentermine
Mephobarbital
CA: CDSA Schedule IV Section 1 Subsection 16 Mephobarbital
US: CSA Schedule IV Section c Subsection 36 Methylphenobarbital
⇒
PubChem: 8271; ChemSpider: 7972; Bluelight: Methylphenobarbital; Erowid: Barbiturates; Wikipedia: Methylphenobarbital
Mepitiostane
UK: MDA Part III Class C Section 1(b) Mepitiostane
MePPP
US: CSA Schedule I Section h Subsection 12 4-Methyl-alpha-pyrrolidinopropiophenone
Meprobamate
CA: CDSA Schedule IV Section 16 Meprobamate
UK: MDA Part III Class C Section 1(a) Meprobamate
UN: Psychotropics Schedule IV Meprobamate
US: CSA Schedule IV Section c Subsection 34 Meprobamate
Meprodine‡
CA: CDSA Schedule I Section 3 Subsection 2 Alphameprodine
UK: MDA Part I Class A Section 1(a) Alphameprodine
UN: Narcotics Part 1 Section 1 Alphameprodine
US: CSA Schedule I Section b Subsection 5 Alphameprodine
Mesabolone
CA: CDSA Schedule IV Section 23 Subsection 20 Mesabolone
UK: MDA Part III Class C Section 1(b) Mesabolone
Mestanolone
UK: MDA Part III Class C Section 1(b) Mestanolone
US: CSA Schedule III Section f Subsection 1 Item 28 Mestanolone
Mesterolone
CA: CDSA Schedule IV Section 23 Subsection 21 Mesterolone
UK: MDA Part III Class C Section 1(b) Mesterolone
US: CSA Schedule III Section f Subsection 1 Item 29 Mesterolone
Metamfetamine
UN: Psychotropics Schedule II Metamfetamine (Methamphetamine)
Metamfetamine racemate
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
Metandienone
CA: CDSA Schedule IV Section 23 Subsection 22 Metandienone
UK: MDA Part III Class C Section 1(b) Methandienone
US: CSA Schedule III Section f Subsection 1 Item 30 Methandienone
Metazocine
CA: CDSA Schedule I Section 11 Subsection 2 Metazocine
UK: MDA Part I Class A Section 1(a) Metazocine and Part II Class B Section 1(a) Metazocine
UN: Narcotics Part 1 Section 1 Metazocine and Psychotropics Schedule III Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
Metenolone
CA: CDSA Schedule IV Section 23 Subsection 23 Metenolone
UK: MDA Part III Class C Section 1(b) Methenolone
US: CSA Schedule III Section f Subsection 1 Item 33 Methenolone
Metethoheptazine
CA: [not controlled] CDSA Schedule I Section 4 Subsection 3 Metethoheptazine
Meth§
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
Methabarbital
CA: CDSA Schedule IV Section 1 Subsection 17 Methabarbital
Methadols
CA: CDSA Schedule I Section 6 Methadols
Methadone intermediate
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
Methadone-intermediate
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-2-dimethylamino-4,4-diphenylbutane
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
Methadyl acetate
CA: CDSA Schedule I Section 6 Subsection 1 Acetylmethadol
UK: MDA Part I Class A Section 1(a) Methadyl acetate
UN: Narcotics Part 1 Section 1 Acetylmethadol
US: CSA Schedule I Section b Subsection 2 Acetylmethadol
Methamphetamine
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Drugs Forum: Methamphetamine; Erowid: Methamphetamines; Wikipedia: Methamphetamine
Methamphetamine
UN: Psychotropics Schedule II Metamfetamine (Methamphetamine)
Methamphetamine racemate
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
Methandienone
CA: CDSA Schedule IV Section 23 Subsection 22 Metandienone
UK: MDA Part III Class C Section 1(b) Methandienone
US: CSA Schedule III Section f Subsection 1 Item 30 Methandienone
Methandriol
CA: CDSA Schedule IV Section 23 Subsection 24 Methandriol
UK: MDA Part III Class C Section 1(b) Methandriol
US: CSA Schedule III Section f Subsection 1 Item 31 Methandriol
Methandrostenolone‡
CA: CDSA Schedule IV Section 23 Subsection 22 Metandienone
UK: MDA Part III Class C Section 1(b) Methandienone
US: CSA Schedule III Section f Subsection 1 Item 30 Methandienone
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
3-Methanone(cyclopropyl)indole
CA: CDSA Schedule II Section 2 Subsection 6 3-Methanone(cyclopropyl)indole
Methaqualone
CA: CDSA Schedule III Section 3 Methaqualone
UK: MDA Part II Class B Section 1(a) Methaqualone
UN: Psychotropics Schedule II Methaqualone
US: CSA Schedule I Section e Subsection 3 Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: Methaqualone
Metharbital‡
CA: CDSA Schedule IV Section 1 Subsection 17 Methabarbital
Methasterone
US: CSA Schedule III Section f Subsection 1 Item 32 Methasterone and Item 73 2α,17α-Dimethyl-17β-hydroxy-5α-androstan-3-one
⇒
PubChem: 237186; ChemSpider: 207079; Bluelight: Superdrol; Erowid: Steroids; Wikipedia: Methasterone
Methcathinone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Methenolone
CA: CDSA Schedule IV Section 23 Subsection 23 Metenolone
UK: MDA Part III Class C Section 1(b) Methenolone
US: CSA Schedule III Section f Subsection 1 Item 33 Methenolone
Metheptazine
CA: [not controlled] CDSA Schedule I Section 4 Subsection 4 Metheptazine
Methiopropamine
UK: MDA Temporary Class Drug Orders 2015 N-Methyl-1-(thiophen-2-yl)propan-2-amine
Methohexital
US: CSA Schedule IV Section c Subsection 35 Methohexital
Methorphan‡
CA: CDSA Schedule I Section 10 Subsection 8 Racemethorphan
UK: MDA Part I Class A Section 1(a) Racemethorphan
UN: Narcotics Part 1 Section 1 Racemethorphan
US: CSA Schedule II Section c Subsection 24 Racemethorphan
Methoxetamine
EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
UK: MDA Part II Class B Section 1(d) Methoxetamine
UK: [revoked] MDA Temporary Class Drug Orders 2012 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
⇒
ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
4-Methoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
5-Methoxy-N,N-diisopropyltryptamine
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-diisopropyltryptamine
US: CSA Schedule I Section d Subsection 20 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
2-(5-Methoxy-2,2-dimethyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(5-Methoxy-2,2-dimethyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
5-Methoxy-N,N-dimethyltryptamine
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-dimethyltryptamine
US: CSA Schedule I Section d Subsection 15 5-Methoxy-N,N-dimethyltryptamine
2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
UK: MDA Part I Class A Section 1(ba) 2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
2-(5-Methoxy-2-methyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
UK: MDA Part I Class A Section 1(ba) 2-(5-Methoxy-2-methyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
5-Methoxy-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
β-Methoxy-3,4-methylenedioxyphenethylamine
UK: MDA Part I Class A Section 1(ba) β-Methoxy-3,4-methylenedioxyphenethylamine
Methoxyphenamine
UK: [not controlled] MDA Part I Class A Section 1(c) Methoxyphenamine
Methyl benzyl ketone
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
Methyl ethyl ketone
CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
EU: Drug precursors Annex I Category 3 Methylethylketone
UK: MDA Drug precursors Annex I Category 3 Methyl ethyl ketone
UN: Precursors Table II Methyl ethyl ketone
US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
Methyl isobutyl ketone
US: CSA Listed Chemicals Section b Subsection 10 Methyl isobutyl ketone
Methylamine
US: CSA Listed Chemicals Section a Subsection 13 Methylamine
2-Methylamino-1-phenyl-1-propanone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
4-Methylaminorex
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
4-Methyl-aminorex
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
(±)-cis-4-Methylaminorex
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
α-Methylaminovalerophenone
US: CSA Schedule I Section h Subsection 15 Pentedrone
⇒
PubChem: 57501499; ChemSpider: 26286729; Bluelight: Pentedrone; Drugs Forum: Pentedrone; Wikipedia: Pentedrone
Methylamphetamine
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
17α-Methyl-androsta-1,4-diene-3,17β-diol
US: CSA Schedule III Section f Subsection 1 Item 79 17α-Methyl-androsta-1,4-diene-3,17β-diol
17α-Methyl-androstan-3-hydroxyimine-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 83 17α-Methyl-androstan-3-hydroxyimine-17β-ol
17α-Methyl-5α-androstan-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 84 17α-Methyl-5α-androstan-17β-ol
17α-Methyl-androst-2-ene-3,17β-diol
US: CSA Schedule III Section f Subsection 1 Item 78 17α-Methyl-androst-2-ene-3,17β-diol
6α-Methyl-androst-4-ene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 82 6α-Methyl-androst-4-ene-3,17-dione
α-Methylbenzeneethanamine
CA: CDSA Schedule I Section 19 Subsection 1 Amphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 1 Amphetamine
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: Amphetamine
Methylcathinone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
N-Methylcathinone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Methyldesorphine
CA: CDSA Schedule I Section 1 Subsection 18 Methyldesorphine
UK: MDA Part I Class A Section 1(a) Methyldesorphine
UN: Narcotics Part 1 Section 1 Methyldesorphine
US: CSA Schedule I Section c Subsection 13 Methyldesorphine
Methyldienolone
US: CSA Schedule III Section f Subsection 1 Item 38 Methyldienolone
Methyldihydromorphine
CA: CDSA Schedule I Section 1 Subsection 19 Methyldihydromorphine
UK: MDA Part I Class A Section 1(a) Methyldihydromorphine
UN: Narcotics Part 1 Section 1 Methyldihydromorphine
US: CSA Schedule I Section c Subsection 14 Methyldihydromorphine
6-Methyldihydromorphine
CA: CDSA Schedule I Section 1 Subsection 19 Methyldihydromorphine
UK: MDA Part I Class A Section 1(a) Methyldihydromorphine
UN: Narcotics Part 1 Section 1 Methyldihydromorphine
US: CSA Schedule I Section c Subsection 14 Methyldihydromorphine
17α-Methyl-Δ1-dihydrotestosterone
US: CSA Schedule III Section f Subsection 1 Item 42 17α-Methyl-Δ1-dihydrotestosterone
⇒
PubChem: 7092657; ChemSpider: 5442174; Bluelight: Methyl-1-Testosterone; Drugs Forum: M-1-T; Erowid: Steroids; Wikipedia: Methyl-1-testosterone
17α-Methyl-3α,17β-dihydroxy-5α-androstane
US: CSA Schedule III Section f Subsection 1 Item 35 17α-Methyl-3α,17β-dihydroxy-5α-androstane
17α-Methyl-3β,17β-dihydroxy-5α-androstane
US: CSA Schedule III Section f Subsection 1 Item 34 17α-Methyl-3β,17β-dihydroxy-5α-androstane
17α-Methyl-3β,17β-dihydroxyandrost-4-ene
US: CSA Schedule III Section f Subsection 1 Item 36 17α-Methyl-3β,17β-dihydroxyandrost-4-ene
4-Methyl-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
3,4-Methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
UK: MDA Part I Class A Section 1(ba) 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
UK: MDA Part I Class A Section 1(ba) 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
⇒
PubChem: 17757316; ChemSpider: 21106348; PiHKAL • info: METHYL-K; Wikipedia: Methylbenzodioxolylpentanamine
3,4-Methylenedioxy-N-ethylamphetamine
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
Methylenedioxymethamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
3,4-Methylenedioxymethamphetamine
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
3,4-Methylenedioxyphenyl-2-propanone
CA: CDSA Schedule VI Part 1 Subsection 9 3,4-Methylenedioxyphenyl-2-propanone
EU: Drug precursors Annex I Category 1 3,4-Methylenedioxyphenylpropan-2-one
UK: MDA Drug precursors Annex I Category 1 3,4-Methylenedioxyphenyl-2-propanone
UN: Precursors Table I 3,4-Methylenedioxyphenyl-2-propanone
US: CSA Listed Chemicals Section a Subsection 12 3,4-Methylenedioxyphenyl-2-propanone
Methylenedioxypyrovalerone
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
US: CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
3,4-Methylenedioxypyrovalerone
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
US: CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
N-Methylephedrine
US: CSA Listed Chemicals Section a Subsection 19 N-Methylephedrine
4-Methyl-N-ethylcathinone
US: CSA Schedule I Section h Subsection 11 4-Methyl-N-ethylcathinone
⇒
PubChem: 52988259; ChemSpider: 25630091; Drugs Forum: (4-MEC); Erowid: 4-Methylethcathinone (4-MEC); Wikipedia: 4-Methylethcathinone
α-Methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
3-Methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 10 3-Methylfentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylfentanyl
UN: Narcotics Part 1 Section 1 3-Methylfentanyl and Section 3 3-Methylfentanyl
US: CSA Schedule I Section b Subsection 34 3-Methylfentanyl
17α-Methyl-4-hydroxynandrolone
US: CSA Schedule III Section f Subsection 1 Item 37 17α-Methyl-4-hydroxynandrolone
METHYL-K†
UK: MDA Part I Class A Section 1(ba) 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
⇒
PubChem: 17757316; ChemSpider: 21106348; PiHKAL • info: METHYL-K; Wikipedia: Methylbenzodioxolylpentanamine
4-Methylmethcathinone
EU: Substances Substances 4-Methylmethcathinone
UK: MDA Part II Class B Section 1(aa) 4-Methylmethcathinone; Mephedrone
US: CSA Schedule I Section d Subsection 36 4-Methylmethcathinone
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
4-Methyl-N-methylcathinone
EU: Substances Substances 4-Methylmethcathinone
UK: MDA Part II Class B Section 1(aa) 4-Methylmethcathinone; Mephedrone
US: CSA Schedule I Section d Subsection 36 4-Methylmethcathinone
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
N-Methyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
UK: MDA Part I Class A Section 1(ba) 2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
⇒
PubChem: 21645837; ChemSpider: 15637662; PiHKAL • info: MDHOET; Wikipedia: Methylenedioxyhydroxyethylamphetamine
α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
UK: MDA Part I Class A Section 1(ba) α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
UK: MDA Part I Class A Section 1(ba) N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
⇒
PubChem: 44350092; ChemSpider: 21106310; PiHKAL • info: FLEA; Wikipedia: Methylenedioxyhydroxymethamphetamine
O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
UK: MDA Part I Class A Section 1(ba) O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
4-Methylmethylphenidate
UK: MDA Temporary Class Drug Orders 2015 4-Methylmethylphenidate
4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine
UK: MDA Part I Class A Section 1(a) 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine
α-Methyl-4-(methylthio)phenethylamine
UK: MDA Part I Class A Section 1(ba) α-Methyl-4-(methylthio)phenethylamine
UN: Psychotropics Schedule I 4-MTA
2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
Methylnaphthidate
UK: MDA Temporary Class Drug Orders 2015 Methylnaphthidate
α-Methylphenethylhydroxylamine
UK: MDA Part II Class B Section 1(a) α-Methylphenethylhydroxylamine
Methylphenidate
CA: CDSA Schedule III Section 2 Methylphenidate
UK: MDA Part II Class B Section 1(a) Methylphenidate
UN: Psychotropics Schedule II Methylphenidate
US: CSA Schedule II Section d Subsection 4 Methylphenidate
⇒
PubChem: 4158; ChemSpider: 4015; Bluelight: Methylphenidate; Drugs Forum: Methylphenidate; Erowid: Methylphenidate; Wikipedia: Methylphenidate
Methylphenobarbital
CA: CDSA Schedule IV Section 1 Subsection 16 Mephobarbital
US: CSA Schedule IV Section c Subsection 36 Methylphenobarbital
⇒
PubChem: 8271; ChemSpider: 7972; Bluelight: Methylphenobarbital; Erowid: Barbiturates; Wikipedia: Methylphenobarbital
Methylphenobarbital
CA: CDSA Schedule IV Section 1 Subsection 18 Methylphenobarbital
UK: MDA Part II Class B Section 1(a) Methylphenobarbitone
UN: Psychotropics Schedule IV Methylphenobarbital
Methylphenobarbitone
CA: CDSA Schedule IV Section 1 Subsection 18 Methylphenobarbital
UK: MDA Part II Class B Section 1(a) Methylphenobarbitone
UN: Psychotropics Schedule IV Methylphenobarbital
![3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine")
1-[1-(4-Methylphenyl)cyclohexyl]piperidine
CA: CDSA Schedule III Section 23 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
UK: MDA Part II Class B Section 1(d) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
Methylphenylisonipecotonitrile
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
1-Methyl-4-phenylpiperidine-4-carboxylic acid
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
1-(1-Methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole
CA: CDSA Schedule II Section 2 Subsection 5 1-(1-Methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole
1-[(N-Methylpiperidin-2-yl)methyl]-3(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-[(N-Methylpiperidin-2-yl)methyl]-3(1-naphthoyl)indole
N-Methyl-3-piperidyl benzilate
CA: CDSA Schedule III Section 8 N-Methyl-3-piperidyl benzilate (LBJ)
US: CSA Schedule I Section d Subsection 28 N-Methyl-3-piperidyl benzilate
N-Methylpseudoephedrine
US: CSA Listed Chemicals Section a Subsection 20 N-Methylpseudoephedrine
4-Methyl-alpha-pyrrolidinopropiophenone
US: CSA Schedule I Section h Subsection 12 4-Methyl-alpha-pyrrolidinopropiophenone
Methyltestosterone
CA: CDSA Schedule IV Section 23 Subsection 25 Methyltestosterone
UK: MDA Part III Class C Section 1(b) Methyltestosterone
US: CSA Schedule III Section f Subsection 1 Item 40 Methyltestosterone
4-Methylthioamphetamine‡
UK: MDA Part I Class A Section 1(ba) α-Methyl-4-(methylthio)phenethylamine
UN: Psychotropics Schedule I 4-MTA
α-Methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
3-Methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 11 3-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 3-Methylthiofentanyl and Section 3 3-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
N-Methyl-1-(thiophen-2-yl)propan-2-amine
UK: MDA Temporary Class Drug Orders 2015 N-Methyl-1-(thiophen-2-yl)propan-2-amine
Methyltrienolone
CA: CDSA Schedule IV Section 23 Subsection 26 Metribolone
UK: MDA Part III Class C Section 1(b) Metribolone
US: CSA Schedule III Section f Subsection 1 Item 39 Methyltrienolone
Methyprylon
CA: CDSA Schedule IV Section 17 Methyprylon
UK: MDA Part III Class C Section 1(a) Methyprylone
UN: Psychotropics Schedule IV Methyprylon
US: CSA Schedule III Section c Subsection 10 Methyprylon
Methyprylone
CA: CDSA Schedule IV Section 17 Methyprylon
UK: MDA Part III Class C Section 1(a) Methyprylone
UN: Psychotropics Schedule IV Methyprylon
US: CSA Schedule III Section c Subsection 10 Methyprylon
Metribolone
CA: CDSA Schedule IV Section 23 Subsection 26 Metribolone
UK: MDA Part III Class C Section 1(b) Metribolone
US: CSA Schedule III Section f Subsection 1 Item 39 Methyltrienolone
Mexxy§
EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
UK: MDA Part II Class B Section 1(d) Methoxetamine
UK: [revoked] MDA Temporary Class Drug Orders 2012 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
⇒
ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
MIBK
US: CSA Listed Chemicals Section b Subsection 10 Methyl isobutyl ketone
Mibolerone
CA: CDSA Schedule IV Section 23 Subsection 27 Mibolerone
UK: MDA Part III Class C Section 1(b) Mibolerone
US: CSA Schedule III Section f Subsection 1 Item 41 Mibolerone
MMDA
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
Mogadon®
CA: CDSA Schedule IV Section 18 Subsection 24 Nitrazepam
UK: MDA Part III Class C Section 1(a) Nitrazepam
UN: Psychotropics Schedule IV Nitrazepam
US: CSA Schedule IV Section c Subsection 39 Nitrazepam
⇒
PubChem: 4506; ChemSpider: 4350; Drugs Forum: Nitrazepam; Erowid: Nitrazepam Synthesis; Wikipedia: Nitrazepam
Monase
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Monomethylpropion
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Moramide intermediate
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
Moramide-intermediate
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UK: MDA Part I Class A Section 1(a) 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
Moramides
CA: CDSA Schedule I Section 9 Moramides
Morphanol‡
CA: CDSA Schedule I Section 10 Subsection 9 Racemorphan
UK: MDA Part I Class A Section 1(a) Racemorphan
UN: Narcotics Part 1 Section 1 Racemorphan
US: CSA Schedule II Section c Subsection 25 Racemorphan
Morpheridine
CA: CDSA Schedule I Section 3 Subsection 15 Morpheridine
UK: MDA Part I Class A Section 1(a) Morpheridine
UN: Narcotics Part 1 Section 1 Morpheridine
US: CSA Schedule I Section b Subsection 36 Morpheridine
Morphinans
CA: CDSA Schedule I Section 10 Morphinans
Morphine methobromide
UK: MDA Part I Class A Section 1(a) Morphine methobromide
UN: Narcotics Part 1 Section 1 Morphine methobromide
US: CSA Schedule I Section c Subsection 15 Morphine methobromide
Morphine methylsulfonate
US: CSA Schedule I Section c Subsection 16 Morphine methylsulfonate
Morphine oxide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
Morphine N-oxide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
Morphine-N-oxide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-200
US: CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
(1-(2-(4-Morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone
CA: CDSA Schedule II Section 2 Subsection 6 (1-(2-(4-Morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone
Morpholinylethylmorphine
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UK: MDA Part II Class B Section 1(a) Pholcodine
UN: Narcotics Part 1 Section 2 Pholcodine and Part 2 Section 1 Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-200
US: CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
MPA
UK: MDA Temporary Class Drug Orders 2015 N-Methyl-1-(thiophen-2-yl)propan-2-amine
MT-45
UK: MDA Part I Class A Section 1(a) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine
MXE†
EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
UK: MDA Part II Class B Section 1(d) Methoxetamine
UK: [revoked] MDA Temporary Class Drug Orders 2012 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
⇒
ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
Nalbuphine
CA: [not controlled] CDSA Schedule I Section 10 Subsection 15 Nalbuphine
⇒
PubChem: 16757775 11957646 12898403 6604372 6603947 5360630 5311304; ChemSpider: 4514550; Wikipedia: Nalbuphine
Nalbuphine
CA: CDSA Schedule IV Section 10 Nalbuphine
⇒
PubChem: 16757775 11957646 12898403 6604372 6603947 5360630 5311304; ChemSpider: 4514550; Wikipedia: Nalbuphine
Nalorphine
CA: CDSA Schedule I Section 1 Subsection 23 Nalorphine
US: CSA Schedule III Section d Subsection d Nalorphine
Naltrexone
CA: [not controlled] CDSA Schedule I Section 1 Subsection 34.2 Naltrexone
Nandrolone
CA: CDSA Schedule IV Section 23 Subsection 28 Nandrolone
UK: MDA Part III Class C Section 1(b) Nandrolone
US: CSA Schedule III Section f Subsection 1 Item 43 Nandrolone
3-(1-Naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 3-(1-Naphthoyl)indole
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)indole
US: CSA Schedule I Section ii Item ii 3-(1-Naphthoyl)indole
3-(2-Naphthoyl)indole
UK: MDA Part II Class B Section 1(c) 3-(2-Naphthoyl)indole
3-(1-Naphthoyl)pyrrole
CA: CDSA Schedule II Section 2 Subsection 3 3-(1-Naphthoyl)pyrrole
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)pyrrole
US: CSA Schedule I Section iii Item iii 3-(1-Naphthoyl)pyrrole
3-(2-Naphthoyl)pyrrole
UK: MDA Part II Class B Section 1(c) 3-(2-Naphthoyl)pyrrole
3-(1-Naphthylmethane)indole
UK: MDA Part II Class B Section 1(c) 1H-Indol-3-yl-(1-naphthyl)methane
US: CSA Schedule I Section ii Item ii 3-(1-Naphthylmethane)indole
1-(1-Naphthylmethylene)indene
UK: MDA Part II Class B Section 1(c) 1-(1-Naphthylmethylene)indene
US: CSA Schedule I Section iv Item iv 1-(1-Naphthylmethylene)indene
1-(2-Naphthylmethylene)indene
UK: MDA Part II Class B Section 1(c) 1-(2-Naphthylmethylene)indene
1-(2-Naphthylmethyl)indene
UK: MDA Part II Class B Section 1(c) 1-(2-Naphthylmethyl)indene
Naphthylpyrovalerone
UK: MDA Part II Class B Section 1(ab) Naphthylpyrovalerone
US: CSA Schedule I Section h Subsection 19 Naphyrone
Naphyrone
UK: MDA Part II Class B Section 1(ab) Naphthylpyrovalerone
US: CSA Schedule I Section h Subsection 19 Naphyrone
Nexus
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
Nicocodeine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
Nicocodine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
Nicodicodeine‡
UK: MDA Part II Class B Section 1(a) Nicodicodine
UN: Narcotics Part 1 Section 2 Nicodicodine and Part 2 Section 1 Nicodicodine
Nicodicodine
UK: MDA Part II Class B Section 1(a) Nicodicodine
UN: Narcotics Part 1 Section 2 Nicodicodine and Part 2 Section 1 Nicodicodine
Nicomorphine
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
6-Nicotinoyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Nicodicodine
UN: Narcotics Part 1 Section 2 Nicodicodine and Part 2 Section 1 Nicodicodine
6-Nicotinylcodeine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
6-Nicotinyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Nicodicodine
UN: Narcotics Part 1 Section 2 Nicodicodine and Part 2 Section 1 Nicodicodine
Nimetazepam
CA: CDSA Schedule IV Section 18 Subsection 23 Nimetazepam
UK: MDA Part III Class C Section 1(a) Nimetazepam
UN: Psychotropics Schedule IV Nimetazepam
US: CSA Schedule IV Section c Subsection 38 Nimetazepam
⇒
PubChem: 4496; ChemSpider: 4340; Drugs Forum: Nimetazepam; Erowid: Nimetazepam; Wikipedia: Nimetazepam
Nitrazepam
CA: CDSA Schedule IV Section 18 Subsection 24 Nitrazepam
UK: MDA Part III Class C Section 1(a) Nitrazepam
UN: Psychotropics Schedule IV Nitrazepam
US: CSA Schedule IV Section c Subsection 39 Nitrazepam
⇒
PubChem: 4506; ChemSpider: 4350; Drugs Forum: Nitrazepam; Erowid: Nitrazepam Synthesis; Wikipedia: Nitrazepam
Nitroethane
US: CSA Listed Chemicals Section a Subsection 23 Nitroethane
Non-human chorionic gonadotrophin
UK: MDA Part III Class C Section 1(e) Non-human chorionic gonadotrophin
Non-viable Cannabis seed
CA: [not controlled] CDSA Schedule II Section 1 Subsection 8 Non-viable Cannabis seed
Noracymethadol
CA: CDSA Schedule I Section 6 Subsection 7 Noracymethadol
UK: MDA Part I Class A Section 1(a) Noracymethadol
UN: Narcotics Part 1 Section 1 Noracymethadol
US: CSA Schedule I Section b Subsection 38 Noracymethadol
19-Nor-4,9(10)-androstadienedione
US: CSA Schedule III Section f Subsection 1 Item 48 19-Nor-4,9(10)-androstadienedione
19-Nor-4-androstenediol
US: CSA Schedule III Section f Subsection 1 Item 45 19-Nor-4-androstenediol
19-Nor-5-androstenediol
UK: MDA Part III Class C Section 1(b) 19-Nor-5-androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 46 19-Nor-5-androstenediol
19-Nor-5-androstenediol
US: CSA Schedule III Section f Subsection 1 Item 47 19-Nor-5-androstenediol
19-Nor-5-androstene-3,17-diol
UK: MDA Part III Class C Section 1(b) 19-Nor-5-androstene-3,17-diol
US: CSA Schedule III Section f Subsection 1 Item 46 19-Nor-5-androstenediol
19-Norandrostenedione
UK: MDA Part III Class C Section 1(b) 19-Norandrostenedione
US: CSA Schedule III Section f Subsection 1 Item 50 19-Nor-5-androstenedione
19-Nor-4-androstenedione
UK: MDA Part III Class C Section 1(b) 19-Nor-4-androstene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 49 19-Nor-4-androstenedione
19-Nor-4-androstene-3,17-dione
UK: MDA Part III Class C Section 1(b) 19-Nor-4-androstene-3,17-dione
US: CSA Schedule III Section f Subsection 1 Item 49 19-Nor-4-androstenedione
19-Nor-5-androstenedione
UK: MDA Part III Class C Section 1(b) 19-Norandrostenedione
US: CSA Schedule III Section f Subsection 1 Item 50 19-Nor-5-androstenedione
19-Norandrosterone
UK: MDA Part III Class C Section 1(b) 19-Norandrosterone
⇒
PubChem: 128251 54364459 44361976 14009229 11778226 10016318 9548753; ChemSpider: 7827676; Wikipedia: 19-Norandrosterone
Norbolethone
CA: CDSA Schedule IV Section 23 Subsection 29 Norboletone
UK: MDA Part III Class C Section 1(b) Norboletone
US: CSA Schedule III Section f Subsection 1 Item 51 Norbolethone
Norboletone
CA: CDSA Schedule IV Section 23 Subsection 29 Norboletone
UK: MDA Part III Class C Section 1(b) Norboletone
US: CSA Schedule III Section f Subsection 1 Item 51 Norbolethone
Norclostebol
CA: CDSA Schedule IV Section 23 Subsection 30 Norclostebol
UK: MDA Part III Class C Section 1(b) Norclostebol
US: CSA Schedule III Section f Subsection 1 Item 52 Norclostebol
Norcodeine
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UK: MDA Part II Class B Section 1(a) Norcodeine
UN: Narcotics Part 1 Section 2 Norcodeine and Part 2 Section 1 Norcodeine
Nordazepam
CA: CDSA Schedule IV Section 18 Subsection 25 Nordazepam
UK: MDA Part III Class C Section 1(a) Nordazepam
UN: Psychotropics Schedule IV Nordazepam
US: CSA Schedule IV Section c Subsection 40 Nordiazepam
⇒
PubChem: 2997; ChemSpider: 2890; Bluelight: Nordiazepam ; Erowid: Nordiazepam Synthesis; Wikipedia: Nordazepam
Nordiazepam
CA: CDSA Schedule IV Section 18 Subsection 25 Nordazepam
UK: MDA Part III Class C Section 1(a) Nordazepam
UN: Psychotropics Schedule IV Nordazepam
US: CSA Schedule IV Section c Subsection 40 Nordiazepam
⇒
PubChem: 2997; ChemSpider: 2890; Bluelight: Nordiazepam ; Erowid: Nordiazepam Synthesis; Wikipedia: Nordazepam
Norephedrine
CA: CDSA Schedule VI Part 1 Subsection 10 Norephedrine
EU: Drug precursors Annex I Category 1 Norephedrine
UK: MDA Drug precursors Annex I Category 1 Norephedrine
UN: Precursors Table I Norephedrine
US: CSA Listed Chemicals Section a Subsection 9 Phenylpropanolamine
⇒
PubChem: 10297 26934; ChemSpider: 9875; Bluelight: Phenylpropanolamine; Erowid: Phenylpropanolamine; Wikipedia: Phenylpropanolamine
Norethandrolone
CA: CDSA Schedule IV Section 23 Subsection 31 Norethandrolone
UK: MDA Part III Class C Section 1(b) Norethandrolone
US: CSA Schedule III Section f Subsection 1 Item 53 Norethandrolone
19-Noretiocholanolone
UK: MDA Part III Class C Section 1(b) 19-Noretiocholanolone
Norlevorphanol
CA: CDSA Schedule I Section 10 Subsection 6 Norlevorphanol
UK: MDA Part I Class A Section 1(a) Norlevorphanol
UN: Narcotics Part 1 Section 1 Norlevorphanol
US: CSA Schedule I Section b Subsection 39 Norlevorphanol
Normethadone
CA: CDSA Schedule I Section 5 Subsection 5 Normethadone
UK: MDA Part I Class A Section 1(a) Normethadone
UN: Narcotics Part 1 Section 1 Normethadone
US: CSA Schedule I Section b Subsection 40 Normethadone
Normethandrolone
US: CSA Schedule III Section f Subsection 1 Item 54 Normethandrolone
Normorphine
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UK: MDA Part I Class A Section 1(a) Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
Norpethidine
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
Norpipanone
CA: CDSA Schedule I Section 5 Subsection 6 Norpipanone
UK: MDA Part I Class A Section 1(a) Norpipanone
UN: Narcotics Part 1 Section 1 Norpipanone
US: CSA Schedule I Section b Subsection 41 Norpipanone
(+)-Norpseudoephedrine
CA: CDSA Schedule IV Section 19 Subsection 1 Cathine
UK: MDA Part III Class C Section 1(a) Cathine
UN: Psychotropics Schedule III Cathine ((+)-Norpseudoephedrine)
US: CSA Schedule IV Section f Subsection 1 Cathine
Norpseudoephedrine
US: CSA Listed Chemicals Section a Subsection 7 Norpseudoephedrine
NPP
US: CSA Listed Chemicals Section a Subsection 28 N-Phenylethyl-4-piperidone
Ohmefentanyl‡
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
Olanzapine
CA: [not controlled] CDSA Schedule IV Section 18 Subsection 34 Olanzapine
Opium
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: OpiumOpium extracts
US: CSA Schedule II Section b Subsection 1 Item x Opium extracts
Opium fluid
US: CSA Schedule II Section b Subsection 1 Item xi Opium fluid
Opium poppy
CA: CDSA Schedule I Section 1 Opium poppy
US: CSA Schedule II Section b Subsection 3 Opium poppy
Ovandrotone
UK: MDA Part III Class C Section 1(b) Ovandrotone
Oxandrolone
CA: CDSA Schedule IV Section 23 Subsection 33 Oxandrolone
UK: MDA Part III Class C Section 1(b) Oxandrolone
US: CSA Schedule III Section f Subsection 1 Item 55 Oxandrolone
⇒
PubChem: 5878; ChemSpider: 5667; Bluelight: Oxandrolone; Drugs Forum: Oxandrolone; Erowid: Steroids; Wikipedia: Oxandrolone
Oxazepam
Oxpheneridine
CA: [not controlled] CDSA Schedule I Section 3 Subsection 24 Oxpheneridine
Oxymesterone
CA: CDSA Schedule IV Section 23 Subsection 34 Oxymesterone
UK: MDA Part III Class C Section 1(b) Oxymesterone
US: CSA Schedule III Section f Subsection 1 Item 56 Oxymesterone
Oxymetholone
CA: CDSA Schedule IV Section 23 Subsection 35 Oxymetholone
UK: MDA Part III Class C Section 1(b) Oxymetholone
US: CSA Schedule III Section f Subsection 1 Item 57 Oxymetholone
⇒
PubChem: 3032303; ChemSpider: 4444502; Bluelight: Oxymetholone; Erowid: Steroids; Wikipedia: Oxymetholone
Oxymorphone
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UK: MDA Part I Class A Section 1(a) Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: OxymorphonePapaver somniverum‡
CA: CDSA Schedule I Section 1 Opium poppy
US: CSA Schedule II Section b Subsection 3 Opium poppy
Papaverine
CA: [not controlled] CDSA Schedule I Section 1 Subsection 36 Papaverine
Para-Ethoxyamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 16 4-Ethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 17 4-Ethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethoxyamphetamine
Para-Fluorofentanyl
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
Para-fluorofentanyl
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
Parafluorofentanyl‡
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
Paraldehyde
US: CSA Schedule IV Section c Subsection 43 Paraldehyde
⇒
PubChem: 31264; ChemSpider: 21106173; Bluelight: Paraldehyde ; Erowid: Paraldehyde Synthesis; Wikipedia: Paraldehyde
Paramethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
PB-22
CA: CDSA Schedule II Section 2 Subsection 7 1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 7 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
PCC
US: CSA Schedule II Section g Subsection 2 Item ii 1-Piperidinocyclohexanecarbonitrile
PCE
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
PCP
CA: CDSA Schedule I Section 14 Phencyclidine
UK: MDA Part I Class A Section 1(a) Phencyclidine
UN: Psychotropics Schedule II Phencyclidine (PCP)
US: CSA Schedule II Section e Subsection 4 Phencyclidine
⇒
PubChem: 6468; ChemSpider: 6224; Bluelight: PCP; Drugs Forum: Phencyclidine; Erowid: PCP; Wikipedia: Phencyclidine
PCPY
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
Pentazocine
CA: CDSA Schedule I Section 11 Subsection 3 Pentazocine
US: CSA Schedule IV Section g Subsection 1 Pentazocine
⇒
PubChem: 4736; ChemSpider: 390041; Bluelight: Pentazocine; Drugs Forum: Pentazocine; Wikipedia: Pentazocine
Pentedrone
US: CSA Schedule I Section h Subsection 15 Pentedrone
⇒
PubChem: 57501499; ChemSpider: 26286729; Bluelight: Pentedrone; Drugs Forum: Pentedrone; Wikipedia: Pentedrone
1-(4-Pentenyl)-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-(4-Pentenyl)-3-(1-naphthoyl)indole
Pentobarbital
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
UN: Psychotropics Schedule III Pentobarbital
US: CSA Schedule II Section e Subsection 3 Pentobarbital, Schedule III Section c Subsection 1 Item iii Pentobarbital and Subsection 2 Item iii Pentobarbital
⇒
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital
1-Pentyl-3-(2-chlorophenylacetyl)indole
US: CSA Schedule I Section g Subsection 15 1-Pentyl-3-(2-chlorophenylacetyl)indole
1-Pentyl-3-(4-ethyl-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole
1-Pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole
CA: CDSA Schedule II Section 2 Subsection 3 1-Pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) UR-144
US: CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) UR-144
US: CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
![3D rendering of 1-Pentyl-3-[(4-methoxy)-benzoyl]indole](data:image/png;base64,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 "Click for a 3D rendering of 1-Pentyl-3-[(4-methoxy)-benzoyl]indole")
1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-081
US: CSA Schedule I Section g Subsection 8 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
1-Pentyl-3-(2-methoxy-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(2-methoxy-1-naphthoyl)indole
1-Pentyl-3-(2-methoxyphenylacetyl)indole
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(2-methoxyphenylacetyl)indole
UK: MDA Part II Class B Section 1(c) JWH-250
US: CSA Schedule I Section g Subsection 7 1-Pentyl-3-(2-methoxyphenylacetyl)indole
1-Pentyl-3-(3-methoxyphenylacetyl)indole
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(3-methoxyphenylacetyl)indole
1-Pentyl-3-(4-methyl-1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-122
US: CSA Schedule I Section g Subsection 9 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
1-Pentyl-3-(2-methylphenylacetyl)indole
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(2-methylphenylacetyl)indole
1-Pentyl-3-(1-naphthoyl)indole
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-018
US: CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
CA: CDSA Schedule II Section 2 Subsection 7 1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 7 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
Perampanel
US: CSA Schedule III Section c Subsection 11 Perampanel
Pethidine [derivatives]
CA: CDSA Schedule I Section 3 Phenylpiperidines
UK: MDA Part I Class A Section 1(e) Pethidine [derivatives]
Pethidine intermediate A
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
Pethidine intermediate B
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
Pethidine intermediate C
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
Pethidine-intermediate-A
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UK: MDA Part I Class A Section 1(a) 4-Cyano-1-methyl-4-phenylpiperidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
Pethidine-intermediate-B
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
Pethidine-intermediate-C
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
Pethidinic acid‡
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UK: MDA Part I Class A Section 1(a) 1-Methyl-4-phenylpiperidine-4-carboxylic acid
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
Petrichloral
US: CSA Schedule IV Section c Subsection 44 Petrichloral
Peyote
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
US: CSA Schedule I Section d Subsection 26 Peyote
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
Phenadoxone
CA: CDSA Schedule I Section 5 Subsection 7 Phenadoxone
UK: MDA Part I Class A Section 1(a) Phenadoxone
UN: Narcotics Part 1 Section 1 Phenadoxone
US: CSA Schedule I Section b Subsection 44 Phenadoxone
Phenalkoxams
CA: CDSA Schedule I Section 7 Phenalkoxams
Phenampromide
CA: CDSA Schedule I Section 12 Subsection 2 Phenampromide
UK: MDA Part I Class A Section 1(a) Phenampromide
UN: Narcotics Part 1 Section 1 Phenampromide
US: CSA Schedule I Section b Subsection 45 Phenampromide
Phenazepines
CA: CDSA Schedule I Section 4 Phenazepines
Phenazocine
CA: CDSA Schedule I Section 11 Subsection 1 Phenazocine
UK: MDA Part I Class A Section 1(a) Phenazocine
UN: Narcotics Part 1 Section 1 Phenazocine
US: CSA Schedule II Section c Subsection 22 Phenazocine
Phencyclidine
CA: CDSA Schedule I Section 14 Phencyclidine
UK: MDA Part I Class A Section 1(a) Phencyclidine
UN: Psychotropics Schedule II Phencyclidine (PCP)
US: CSA Schedule II Section e Subsection 4 Phencyclidine
⇒
PubChem: 6468; ChemSpider: 6224; Bluelight: PCP; Drugs Forum: Phencyclidine; Erowid: PCP; Wikipedia: Phencyclidine
Phendimetrazine
CA: CDSA Schedule IV Section 5 Phendimetrazine
UK: MDA Part III Class C Section 1(a) Phendimetrazine
UN: Psychotropics Schedule IV Phendimetrazine
US: CSA Schedule III Section b Subsection 5 Phendimetrazine
Phenethylamine
UK: [not controlled] MDA Part I Class A Section 1(ba) Phenethylamine and Section 1(c) Phenethylamine
N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide
US: CSA Schedule I Section h Subsection 24 N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide
Phenmetrazine
CA: CDSA Schedule IV Section 6 Phenmetrazine
UK: MDA Part II Class B Section 1(a) Phenmetrazine
UN: Psychotropics Schedule II Phenmetrazine
US: CSA Schedule II Section d Subsection 3 Phenmetrazine
Phenobarbital
CA: CDSA Schedule IV Section 1 Subsection 21 Phenobarbital
UN: Psychotropics Schedule IV Phenobarbital
US: CSA Schedule IV Section c Subsection 45 Phenobarbital
⇒
PubChem: 4763; ChemSpider: 4599; Bluelight: Phenobarbital vs. benzo's; Drugs Forum: Phenobarbital; Erowid: Barbiturates; Wikipedia: Phenobarbital
Phenomorphan
CA: CDSA Schedule I Section 10 Subsection 7 Phenomorphan
UK: MDA Part I Class A Section 1(a) Phenomorphan
UN: Narcotics Part 1 Section 1 Phenomorphan
US: CSA Schedule I Section b Subsection 46 Phenomorphan
Phenoperidine
CA: CDSA Schedule I Section 3 Subsection 18 Phenoperidine
UK: MDA Part I Class A Section 1(a) Phenoperidine
UN: Narcotics Part 1 Section 1 Phenoperidine
US: CSA Schedule I Section b Subsection 47 Phenoperidine
Phentermine
CA: CDSA Schedule IV Section 8 Phentermine
UK: MDA Part III Class C Section 1(a) Phentermine
UN: Psychotropics Schedule IV Phentermine
US: CSA Schedule IV Section f Subsection 9 Phentermine
Phenylacetic acid
CA: CDSA Schedule VI Part 1 Subsection 12 Phenylacetic acid
EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
UK: MDA Drug precursors Annex I Category 2 Phenylacetic acid and Drug precursors Annex II Phenylacetic acid
UN: Precursors Table II Phenylacetic acid
US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
⇒
PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
Phenylacetone
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
3-Phenylacetylindole
CA: CDSA Schedule II Section 2 Subsection 4 3-Phenylacetylindole
UK: MDA Part II Class B Section 1(c) 3-Phenylacetylindole
US: CSA Schedule I Section v Item v 3-Phenylacetylindole
1-Phenylcyclohexylamine
US: CSA Schedule II Section g Subsection 2 Item i 1-Phenylcyclohexylamine
1-Phenylcyclohexylamine
UK: MDA Part II Class B Section 1(d) 1-Phenylcyclohexylamine
N-(1-Phenylcyclohexyl)ethylamine
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
N-Phenylethyl-4-piperidone
US: CSA Listed Chemicals Section a Subsection 28 N-Phenylethyl-4-piperidone
Phenylmethylbarbituric acid
CA: CDSA Schedule IV Section 1 Subsection 23 Phenylmethylbarbituric acid
![3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine")
1-[1-(Phenylmethyl)cyclohexyl]piperidine
CA: CDSA Schedule III Section 22 1-[1-(Phenylmethyl)cyclohexyl]piperidine
1-Phenylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Phenylpiperazine
4-Phenylpiperidine-4-carboxylic acid ethyl ester
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UK: MDA Part I Class A Section 1(a) 4-Phenylpiperidine-4-carboxylic acid ethyl ester
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
Phenylpiperidines
CA: CDSA Schedule I Section 3 Phenylpiperidines
UK: MDA Part I Class A Section 1(e) Pethidine [derivatives]
Phenylpropanolamine
CA: CDSA Schedule VI Part 1 Subsection 10 Norephedrine
EU: Drug precursors Annex I Category 1 Norephedrine
UK: MDA Drug precursors Annex I Category 1 Norephedrine
UN: Precursors Table I Norephedrine
US: CSA Listed Chemicals Section a Subsection 9 Phenylpropanolamine
⇒
PubChem: 10297 26934; ChemSpider: 9875; Bluelight: Phenylpropanolamine; Erowid: Phenylpropanolamine; Wikipedia: Phenylpropanolamine
Phenylpropanolamine
UK: [not controlled] MDA Part III Class C Section 2 Phenylpropanolamine
1-Phenyl-2-propanone
CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UK: MDA Drug precursors Annex I Category 1 1-Phenyl-2-propanone
UN: Precursors Table I 1-Phenyl-2-propanone
US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
1-Phenyl-N-propylcyclohexanamine
CA: CDSA Schedule III Section 15 1-Phenyl-N-propylcyclohexanamine
UK: MDA Part II Class B Section 1(d) 1-Phenyl-N-propylcyclohexanamine
Pholcodine
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UK: MDA Part II Class B Section 1(a) Pholcodine
UN: Narcotics Part 1 Section 2 Pholcodine and Part 2 Section 1 Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
PHP
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
Piminodine
CA: CDSA Schedule I Section 3 Subsection 19 Piminodine
UK: MDA Part I Class A Section 1(a) Piminodine
UN: Narcotics Part 1 Section 1 Piminodine
US: CSA Schedule II Section c Subsection 23 Piminodine
Piperidine
CA: CDSA Schedule VI Part 1 Subsection 13 Piperidine
EU: Drug precursors Annex I Category 2 Piperidine and Annex II Piperidine
UK: MDA Drug precursors Annex I Category 2 Piperidine and Drug precursors Annex II Piperidine
UN: Precursors Table II Piperidine
US: CSA Listed Chemicals Section a Subsection 10 Piperidine
⇒
PubChem: 8082; ChemSpider: 7791; Drugs Forum: Piperidines; Erowid: Piperidine; Wikipedia: Piperidine
1-Piperidinocyclohexanecarbonitrile
US: CSA Schedule II Section g Subsection 2 Item ii 1-Piperidinocyclohexanecarbonitrile
Piritramide
CA: CDSA Schedule I Section 15 Piritramide
UK: MDA Part I Class A Section 1(a) Piritramide
UN: Narcotics Part 1 Section 1 Piritramide
US: CSA Schedule I Section b Subsection 48 Piritramide
PMA
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
Poppy‡
CA: CDSA Schedule I Section 1 Opium poppy
US: CSA Schedule II Section b Subsection 3 Opium poppy
Poppy, opium
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: OpiumPoppy seed
CA: [not controlled] CDSA Schedule I Section 1 Subsection 37 Poppy seed
Poppy straw
UK: MDA Part I Class A Section 1(a) Poppy-straw
US: CSA Schedule II Section b Subsection 3 Poppy straw
Poppy-straw
UK: MDA Part I Class A Section 1(a) Poppy-straw
US: CSA Schedule II Section b Subsection 3 Poppy straw
Potassium permanganate
CA: CDSA Schedule VI Part 1 Subsection 15 Potassium permanganate
EU: Drug precursors Annex I Category 2 Potassium permanganate and Annex II Potassium permanganate
UK: MDA Drug precursors Annex I Category 2 Potassium permanganate and Drug precursors Annex II Potassium permanganate
UN: Precursors Table I Potassium permanganate
US: CSA Listed Chemicals Section b Subsection 5 Potassium permanganate
⇒
PubChem: 516875; ChemSpider: 22810; Bluelight: KMnO4 substitute; Wikipedia: Potassium permanganatePowdered opium
US: CSA Schedule II Section b Subsection 1 Item xv Powdered opium
Prasterone
CA: CDSA Schedule IV Section 23 Subsection 36 Prasterone
UK: MDA Part III Class C Section 1(b) Prasterone
Pregabalin
US: CSA Schedule V Section e Subsection 3 Pregabalin
⇒
PubChem: 5486971; ChemSpider: 3902475; Bluelight: Pregabalin; Drugs Forum: Pregabalin; Erowid: Pregabalin; Wikipedia: Pregabalin
Probarbital
CA: CDSA Schedule IV Section 1 Subsection 22 Probarbital
Prodine‡
CA: CDSA Schedule I Section 3 Subsection 3 Alphaprodine
UK: MDA Part I Class A Section 1(a) Alphaprodine
UN: Narcotics Part 1 Section 1 Alphaprodine
US: CSA Schedule II Section c Subsection 2 Alphaprodine
Proheptazine
CA: CDSA Schedule I Section 4 Subsection 1 Proheptazine
UK: MDA Part I Class A Section 1(a) Proheptazine
UN: Narcotics Part 1 Section 1 Proheptazine
US: CSA Schedule I Section b Subsection 49 Proheptazine
Propallylonal
CA: CDSA Schedule IV Section 1 Subsection 19 Propallylonal
Propanoic anhydride‡
US: CSA Listed Chemicals Section a Subsection 15 Propionic anhydride
Properidine
CA: CDSA Schedule I Section 3 Subsection 20 Properidine
UK: MDA Part I Class A Section 1(a) Properidine
UN: Narcotics Part 1 Section 1 Properidine
US: CSA Schedule I Section b Subsection 50 Properidine
Propetandrol
UK: MDA Part III Class C Section 1(b) Propetandrol
Propionic anhydride
US: CSA Listed Chemicals Section a Subsection 15 Propionic anhydride
Propylhexedrine
CA: CDSA Schedule V Section 2 Propylhexedrine
N-Propyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 18 N-Propyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 19 N-Propyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Propyl-3,4-methylenedioxyamphetamine
Propylphenidate
UK: MDA Temporary Class Drug Orders 2015 Propylphenidate
Prostanozol
UK: MDA Part III Class C Section 1(b) Prostanozol
US: CSA Schedule III Section f Subsection 1 Item 58 Prostanozol and Item 89 [3,2-c]Pyrazole-5α-androstan-17β-ol
Prostanozol, O-tetrahydropyran-2-yl
UK: MDA Part III Class C Section 1(b) Prostanozol, O-tetrahydropyran-2-yl
US: [not controlled] CSA Schedule III Section f Subsection 1 Prostanozol, O-tetrahydropyran-2-yl
Pseudoephedrine
CA: CDSA Schedule VI Part 1 Subsection 16 Pseudoephedrine
EU: Drug precursors Annex I Category 1 Pseudoephedrine
UK: MDA Drug precursors Annex I Category 1 Pseudoephedrine
UN: Precursors Table I Pseudoephedrine
US: CSA Listed Chemicals Section a Subsection 11 Pseudoephedrine
⇒
PubChem: 7028; ChemSpider: 6761; Bluelight: Pseudoephedrine; Drugs Forum: Pseudoephedrine; Erowid: Ephedrine; Wikipedia: Pseudoephedrine
Psilocin
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
Psilocine
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
Psilocybin
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
Psilocybine
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
Psilocyn
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
Psilotsin
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
[3,2-c]Pyrazole-5α-androstan-17β-ol
UK: MDA Part III Class C Section 1(b) Prostanozol
US: CSA Schedule III Section f Subsection 1 Item 58 Prostanozol and Item 89 [3,2-c]Pyrazole-5α-androstan-17β-ol
![3D rendering of [3,2-c]Pyrazole-androst-4-en-17β-ol](data:image/png;base64,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 "Click for a 3D rendering of [3,2-c]Pyrazole-androst-4-en-17β-ol")
[3,2-c]Pyrazole-androst-4-en-17β-ol
US: CSA Schedule III Section f Subsection 1 Item 88 [3,2-c]Pyrazole-androst-4-en-17β-ol
Pyrovalerone
CA: CDSA Schedule IV Section 26 Pyrovalerone
UK: MDA Part II Class B Section 1(aa) Pyrovalerone and Part III Class C Section 1(a) Pyrovalerone
UN: Psychotropics Schedule IV Pyrovalerone
US: CSA Schedule V Section d Subsection 1 Pyrovalerone
Pyrrolidine analog of Phencyclidine
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
α-Pyrrolidinopentiophenone
US: CSA Schedule I Section h Subsection 13 alpha-Pyrrolidinopentiophenone
⇒
PubChem: 11148955; ChemSpider: 9324063; Drugs Forum: ?-PVP; Wikipedia: alpha-Pyrrolidinopentiophenone
Quinbolone
CA: CDSA Schedule IV Section 23 Subsection 37 Quinbolone
UK: MDA Part III Class C Section 1(b) Quinbolone
Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
CA: CDSA Schedule II Section 2 Subsection 7 1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 8 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Quinolin-8-yl 1H-indole-3-carboxylate
CA: CDSA Schedule II Section 2 Subsection 7 Quinolin-8-yl 1H-indole-3-carboxylate
Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
CA: CDSA Schedule II Section 2 Subsection 7 1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 7 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
QUPIC
CA: CDSA Schedule II Section 2 Subsection 7 1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
US: CSA Schedule I Section h Subsection 7 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
Racemethorphan
CA: CDSA Schedule I Section 10 Subsection 8 Racemethorphan
UK: MDA Part I Class A Section 1(a) Racemethorphan
UN: Narcotics Part 1 Section 1 Racemethorphan
US: CSA Schedule II Section c Subsection 24 Racemethorphan
Racemoramide
CA: CDSA Schedule I Section 9 Subsection 4 Racemoramide
UK: MDA Part I Class A Section 1(a) Racemoramide
UN: Narcotics Part 1 Section 1 Racemoramide
US: CSA Schedule I Section b Subsection 52 Racemoramide
Racemorphan
CA: CDSA Schedule I Section 10 Subsection 9 Racemorphan
UK: MDA Part I Class A Section 1(a) Racemorphan
UN: Narcotics Part 1 Section 1 Racemorphan
US: CSA Schedule II Section c Subsection 25 Racemorphan
Raw opium
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: Opium
Red phosphorous
CA: CDSA Schedule VI Part 1 Subsection 20 Red phosphorous
US: CSA Listed Chemicals Section a Subsection 25 Red phosphorus
Red phosphorus
CA: CDSA Schedule VI Part 1 Subsection 20 Red phosphorous
US: CSA Listed Chemicals Section a Subsection 25 Red phosphorus
Remifentanil
CA: CDSA Schedule I Section 16 Subsection 11.1 Remifentanil
UK: MDA Part I Class A Section 1(a) Remifentanil
UN: Narcotics Part 1 Section 1 Remifentanil
US: CSA Schedule II Section c Subsection 26 Remifentanil
Resin of Indian hemp
CA: CDSA Schedule II Section 1 Subsection 1 Cannabis resin, Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
UK: MDA Part II Class B Section 1(a) Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
Rivotril®
CA: CDSA Schedule IV Section 18 Subsection 6 Clonazepam
UK: MDA Part III Class C Section 1(a) Clonazepam
UN: Psychotropics Schedule IV Clonazepam
US: CSA Schedule IV Section c Subsection 11 Clonazepam
⇒
PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
Rohypnol®
CA: CDSA Schedule I Section 20 Flunitrazepam
CA: [revoked] CDSA Schedule III Section 25 Flunitrazepam
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Rolicyclidine
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
Roxibolone
UK: MDA Part III Class C Section 1(b) Roxibolone
Safrole
CA: CDSA Schedule VI Part 1 Subsection 17 Safrole
EU: Drug precursors Annex I Category 1 Safrole
UK: MDA Drug precursors Annex I Category 1 Safrole
UN: Precursors Table I Safrole
US: CSA Listed Chemicals Section a Subsection 17 Safrole
⇒
PubChem: 5144; ChemSpider: 13848731; Bluelight: Safrole; Erowid: Safrole Synthesis; Wikipedia: SafroleSalvia divinorum
CA: CDSA Schedule IV Section 27 Salvia divinorum
Salvinorin A
CA: CDSA Schedule IV Section 27 Subsection 1 Salvinorin A
⇒
PubChem: 128563; ChemSpider: 113947; Bluelight: Salvinorin A; Drugs Forum: Salvinorin A; Erowid: Salvia Divinorum; Wikipedia: Salvinorin A
Secbutabarbital
CA: CDSA Schedule IV Section 1 Subsection 7 Butabarbital
UN: Psychotropics Schedule IV Secbutabarbital
Secobarbital
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
UN: Psychotropics Schedule II Secobarbital
US: CSA Schedule II Section e Subsection 5 Secobarbital, Schedule III Section c Subsection 1 Item ii Secobarbital and Subsection 2 Item ii Secobarbital
⇒
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
Sibutramine
US: CSA Schedule IV Section f Subsection 11 Sibutramine
⇒
PubChem: 5210; ChemSpider: 5021; Bluelight: Sibutramine (amphetamines); Drugs Forum: Sibutramine addiction; Wikipedia: Sibutramine
Silandrone
UK: MDA Part III Class C Section 1(b) Silandrone
Sodium oxybate
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Sodium oxybutyrate
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Sodium permanganate
US: CSA Listed Chemicals Section b Subsection 11 Sodium permanganate
Somatotropin
UK: MDA Part III Class C Section 1(e) Somatotropin
Somatropin
UK: MDA Part III Class C Section 1(e) Somatropin
SPA
CA: CDSA Schedule III Section 29 Lefetamine
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
Stanolone
CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
UK: MDA Part III Class C Section 1(b) Stanolone
US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
Stanozolol
CA: CDSA Schedule IV Section 23 Subsection 38 Stanozolol
UK: MDA Part III Class C Section 1(b) Stanozolol
US: CSA Schedule III Section f Subsection 1 Item 59 Stanozolol
Stenbolone
CA: CDSA Schedule IV Section 23 Subsection 39 Stenbolone
UK: MDA Part III Class C Section 1(b) Stenbolone
US: CSA Schedule III Section f Subsection 1 Item 60 Stenbolone
STP
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
STS-135
CA: CDSA Schedule II Section 2 Subsection 9 N-(Adamantan-1-yl)-1-fluoropentylindole-3-carboxamide
⇒
PubChem: 57404059; ChemSpider: 28189067; Bluelight: STS-135; Drugs Forum: STS-135; Wikipedia: STS-135 (drug)
Sufentanil
CA: CDSA Schedule I Section 16 Subsection 12 Sufentanil
UK: MDA Part I Class A Section 1(a) Sufentanil
UN: Narcotics Part 1 Section 1 Sufentanil
US: CSA Schedule II Section c Subsection 27 Sufentanil
⇒
PubChem: 41693; ChemSpider: 38043; Bluelight: Sufentanil; Erowid: Sufentanil total synthesis; Wikipedia: Sufentanil
Sulfondiethylmethane
US: CSA Schedule III Section c Subsection 12 Sulfondiethylmethane
Sulfonethylmethane
US: CSA Schedule III Section c Subsection 13 Sulfonethylmethane
Sulfonmethane
US: CSA Schedule III Section c Subsection 14 Sulfonmethane
Sulfuric acid
CA: CDSA Schedule VI Part 2 Subsection 5 Sulphuric acid
EU: Drug precursors Annex I Category 3 Sulphuric acid
UK: MDA Drug precursors Annex I Category 3 Sulphuric acid
UN: Precursors Table II Sulphuric acid
US: CSA Listed Chemicals Section b Subsection 9 Sulfuric acid
Sulphuric acid
CA: CDSA Schedule VI Part 2 Subsection 5 Sulphuric acid
EU: Drug precursors Annex I Category 3 Sulphuric acid
UK: MDA Drug precursors Annex I Category 3 Sulphuric acid
UN: Precursors Table II Sulphuric acid
US: CSA Listed Chemicals Section b Subsection 9 Sulfuric acid
Suvorexant
US: CSA Schedule IV Section c Subsection 49 Suvorexant
Tapentadol
CA: CDSA Schedule I Section 22 Tapentadol
UK: MDA Part I Class A Section 1(a) Tapentadol
US: CSA Schedule II Section c Subsection 28 Tapentadol
⇒
PubChem: 9838022; ChemSpider: 8013742; Bluelight: Tapentadol; Drugs Forum: Tapentadol; Erowid: Tapentadol; Wikipedia: Tapentadol
TCP
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
TCPy
UK: MDA Part II Class B Section 1(d) TCPy
US: CSA Schedule I Section d Subsection 35 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
Tenamfetamine
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
Tenocyclidine
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
Testolactone
US: CSA Schedule III Section f Subsection 1 Item 61 Testolactone
Testosterone
CA: CDSA Schedule IV Section 23 Subsection 40 Testosterone
UK: MDA Part III Class C Section 1(b) Testosterone
US: CSA Schedule III Section f Subsection 1 Item 62 Testosterone
1-Testosterone
US: CSA Schedule III Section f Subsection 1 Item 18 Δ1-Dihydrotestosterone
Tetrahydrocannabinol
CA: CDSA Schedule II Section 1 Subsection 7 Tetrahydrocannabinol
UK: MDA Part II Class B Section 1(a) Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ1 cis or trans Tetrahydrocannabinol
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: TetrahydrocannabinolTetrahydrocannabinol
UN: Psychotropics Schedule I Tetrahydrocannabinol
Δ1 cis or trans Tetrahydrocannabinol
CA: CDSA Schedule II Section 1 Subsection 7 Tetrahydrocannabinol
UK: MDA Part II Class B Section 1(a) Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ1 cis or trans Tetrahydrocannabinol
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: Tetrahydrocannabinol
Δ3,4 cis or trans Tetrahydrocannabinol
UN: Psychotropics Schedule I 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
US: CSA Schedule I Section d Subsection 31 Δ3,4 cis or trans Tetrahydrocannabinol
Δ6 cis or trans Tetrahydrocannabinol
UN: Psychotropics Schedule I (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
US: CSA Schedule I Section d Subsection 31 Δ6 cis or trans Tetrahydrocannabinol
Tetrahydrocannabinols
US: CSA Schedule I Section d Subsection 31 Tetrahydrocannabinols
Tetrahydrogestrinone
UK: MDA Part III Class C Section 1(b) Tetrahydrogestrinone
US: CSA Schedule III Section f Subsection 1 Item 63 Tetrahydrogestrinone
⇒
PubChem: 25320811 6857686; ChemSpider: 5257020; Bluelight: Tetrahydrogestrinone; Erowid: Steroids; Wikipedia: Tetrahydrogestrinone![3D rendering of 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
US: CSA Schedule I Section d Subsection 31 Δ6 cis or trans Tetrahydrocannabinol
![3D rendering of (6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,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 "Click for a 3D rendering of (6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
(6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I (6aR,9R,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
US: CSA Schedule I Section d Subsection 31 Δ3,4 cis or trans Tetrahydrocannabinol
![3D rendering of (9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAQkAAACgCAIAAACQbg6hAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC42MG0jaeMAAAmvSURBVHic7d1NjptIGwfwx6/ebZTU7LKLsJQLgNQXwEfwFXAuEMER8BFAmgvgVdZGirKMZNSL7CLBIpuWogj22dS7qLyIsR8wbYoqPP3/aRYz7h4+2vzrA+N6VlJKAoAL/7F9AAALhWwA8JANAB6yAcBDNgB4yAYAD9kA4CEbADxkA4CHbADwkA0AHrIBwEM2AHjIBgAP2QDgIRsAPGQDgIdsAPCQDQAesgHAW2g2DodDURS2jwJetIVmI03Tw+Fg+yjgRVtoNgCsQzYAeMgGAA/ZAOAhGwA8ZAOAh2wA8JANAB6yAcBDNgB4yAYAD9kA4CEbADxkA4CHbADwkA0AHrIBwEM2AHjIBgAP2QDgIRsAPGQDgPdf2wfAyPO8qioiqqrKcRzbhwMv1LL6jaZpdrvdZrNxHKeqKs/zoihqmsb2ccFLtKBsRFG0Xq/zPM+y7Hg8lmUZBEGapp7npWlq++jg5ZELkGWZ4zhCiDAM67ru/qiu6yAIiMj3/ePxaOsI4QWynI2yLH3fJ6LtdluWZd+vnU4n9WtBEAz8GoBG1rJR13UYhkTkuu7IDqHbvcx9eAB2spEkiRBCCBHH8bP+R5UoIYTjOFmWzXR4ANJ8No7Ho+u6RHQ5tRhPTdPVJOR0Ouk9QgDFXDa6F7SWOcPxeGwnITfHDKCPiWzMOhBKkmQpk5C6lkEghZBEUggZBLJN7OX9wGXcIYQBs79DBibQi5iE1LUUQoahVF1iWcowlEL8iQeycYdmfIcM33i1PAkJAnkZ/jCUQSAlsnGX5nqHsix71v1ZXdq5vukORAh5mf+ylEJIiWzcpZWUco6P26MoyvP8dDrNsfGrPM/zfT+OY3O7XK2I/Uuq11cr5kfz/OVBlxmfpxJCzLfxxe1aCKqq8xeritojkfIf/8DiLehZw/u23dLlA5FpStutjaMBDZb4/Y27FMe0XhMRBQE5DlUVpSmlKZWl7SODG6Hf0EQIKktqGvI8Wq3I86hpqCzJ3sASJkK/oY8QlCSUJMyPLicYmHIsHvoNzaIo2mw2to8CNEA2AHjIBgAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOAZyIb+/0eZTTg7pjIhuM4KKMBd8dENlT9AN/3VU2moigM7BRgohmzURRFnufq34UQSZIcj0ci8jxvt9vNN8TK8/zx8fHLly/mR3FVVX369Onbt2/I/7/BTOte1XW93W6JKzrTrmD73AIDV7WVbnzff/PmzRy76NOWE3n37t3DwwNhBev7N+/qesfjURV6Paso0F5JjuNoWfjwstLNDbVvbnZZTuTmAiOwHCZWnozjWF0oSZJ0Xy/LUvUtE6sO9G1fjq6ZdrOBOgfa8w+GGVqVdaCkZV/fMsbISjdTdtGne0bdpanPlqnWlX8wz+iKxd2V1c+u0YG2n3XDNdfWIRi5izGbulyRmn1dS7UqMMzCat59FTnaQchwueQpY5W+xv62g2ev8oFSB5iE3Bc7K90PVJPp9i2X/6OWy+u2YmjPmrr0dRSYhNwRm1UgBsZFWZb5vt+9qrQPS8bfSr75lldfkjEJuQv2K6Rcvejnu5LGtOITe6qBXM1xhwA0sp8NhZ2Lmynk15c9jT3VwHjsuTchwJilZENeNLGGC8B2W/HT6aS33PPlLthJiPkScDBgQdlQ2ibWymMXqhVXo6yZeqq+W8ntiaMDWYjFZUN5eHj48OGDlV2rByLb/5wjnAO3kn3ft18oHaSUUi70e3+vXr16/fq17aMgIlqv19ofqlWzC1UodO6nkuFmC83GcjRNM9OF206r8jxHyY4FQt0my4Ig2G636DcWCNmwT93DtX0UcA5jKgAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOAh2wA8JANAB6yAcBDNgB4yAYAD9kA4CEbADxkA4CHbNin6iHaPgo4h2zYlOf5er2OogjfbVogZOOKdvFcvaqq2mw2m83Gdd2yLNX6VLAomr8Tm6bp4XCYvp3Hx8efP38GQaAWOzOmaZq///6biNI0bZfJ0b6L/X6/3+/VWgrd7atKhb9+/TJ/4kQURVFRFNvtVp24SYfDIU1T13XV4l2G995nJaXUuLmiKKZnQxXRfPv27dPTUxiGxv5eaZru9/umad6/f//161fXdeM41puNKIpUIek4jruXYFVV+/0+TdOHh4enp6cfP35YOXHf9w+Hwxwn3qcoiiiK8jwPgkBdOerEDez6OtsLZDEcx1EFBoytFXtZdUB7MTRVuIN6Fvw8W/PXyomr05y7ClzrspRXd+nu+ZY/Hm9x2VAXSvuuzF2wYqCUjNS01Hm3oshlyVyVgcu1DOdeJNfAiQ8YqKE1fGAmLSsbZVmyF8ocZQbGL9J+cys+XOVwzCLtc7Ti45vn9sQ1Fpq6WvhKuezQzFtWNtQctO+n7fU0fQ3p5y7SfkMrfnVN6PE519iKP7eciMZ+e6D/HDjaMUGayYKyoRZpvjrQHBiHjNzLDQXNlJGteN87OnGYNHESMiVgE/vtgf5zDI1FTJ9lQdlwXdf3/TG/2R0Ojf976RrIDl9k6hq6bBrVAU+cXt/WiusamN1WrEfLld2my2SJkqVkI0kSInrWO9de6x8/fvzzUl3LIJBCSCIphAwC+f+38Pv373pvgPS14nEcn715fXeobjZ+VDbHJTV+VDZyajGesXtoyiKyUdf1lDHSn2zUtRRChqFUf7WylGEohVDx+Pz5s/a6FlfHSLNOKK+24vMNRa52X3OfuJk6iYvIhnoXp55nEMjLqz8MZRBIKX///j1p4/3YVrw7fpt1DMC24mamsOwkxNiJz3EP7Yz9bJRlSUQazlAIedlElaUUYuqWR+g2Zobnjt1WPEkSw7c+u92XxROf47NC+9nwfd91XQ0b6vuM3+Bn/21jZr4uWbcVN19Qc+LNwynaE9feFmh+nuq5VMkiPc+6/vUXnU509oheVZHnUV1P3Ti8PJazsV6vXdfNskzDtnY7EoLi+B8vRhE1DSWJhu3DC2OzblMURU3TxGdX883imNZrIqIgIMehqqI0pTSlstSzfXhhrH23qWka9R0JbV9UEILKkpqGPI9WK/I8ahoqS1rM9wHgvlgbU+12uzzPT6fTcr7LAtBlZ0yV53maplmWIRiwWHb6DVVOWz1cCLBMFvqNNE3VaMr8rgHGszAXL4oiDEP1YSrAYln+fANgsbA+FQAP2QDgIRsAPGQDgIdsAPCQDQAesgHAQzYAeMgGAA/ZAOAhGwA8ZAOAh2wA8JANAB6yAcBDNgB4yAYAD9kA4CEbADxkA4D3P13saHGFk8P+AAAAAElFTkSuQmCC "Click for a 3D rendering of (9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol")
(9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I (9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
β,3,4,5-Tetramethoxyphenethylamine
UK: MDA Part I Class A Section 1(ba) β,3,4,5-Tetramethoxyphenethylamine
3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole
UK: MDA Part II Class B Section 1(c) 3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole
Tetrazepam
CA: CDSA Schedule IV Section 18 Subsection 31 Tetrazepam
UK: MDA Part III Class C Section 1(a) Tetrazepam
UN: Psychotropics Schedule IV Tetrazepam
US: CSA Schedule IV Section c Subsection 51 Tetrazepam
⇒
PubChem: 25215; ChemSpider: 23551; Bluelight: Tetrazepam; Drugs Forum: Tetrazepam; Wikipedia: Tetrazepam
TFMPP
CA: CDSA Schedule III Section 34 Trifluoromethylphenylpiperazine
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine
Thialbarbital
CA: CDSA Schedule IV Section 2 Subsection 1 Thialbarbital
Thiambutenes
CA: CDSA Schedule I Section 8 Thiambutenes
1-[1-(2-Thienyl)cyclohexyl]piperidine
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
UK: MDA Part II Class B Section 1(d) TCPy
US: CSA Schedule I Section d Subsection 35 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
Thiobarbiturates
CA: CDSA Schedule IV Section 2 Thiobarbiturates
Thiobarbituric acid
CA: CDSA Schedule IV Section 2 Subsection 3 Thiobarbituric acid
Thiofentanyl
CA: CDSA Schedule I Section 16 Subsection 13 Thiofentanyl
UK: MDA Part I Class A Section 1(d) Thiofentanyl
UN: Narcotics Part 1 Section 1 Thiofentanyl and Section 3 Thiofentanyl
US: CSA Schedule I Section b Subsection 53 Thiofentanyl
Thiomesterone
CA: CDSA Schedule IV Section 23 Subsection 42 Tiomesterone
UK: MDA Part III Class C Section 1(b) Thiomesterone
Thiopental
CA: CDSA Schedule IV Section 2 Subsection 4 Thiopental
Thiophene analog of Phencyclidine
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
THJ-2201
US: CSA Schedule I Section h Subsection 23 [1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
Tiletamine
US: CSA Schedule III Section c Subsection 15 Tiletamine
⇒
PubChem: 26533; ChemSpider: 24714; Bluelight: Tiletamine; Drugs Forum: Tiletamine; Erowid: Tiletamine; Wikipedia: Tiletamine
Tincture of opium
US: CSA Schedule II Section b Subsection 1 Item xviii Tincture of opium
Tiomesterone
CA: CDSA Schedule IV Section 23 Subsection 42 Tiomesterone
UK: MDA Part III Class C Section 1(b) Thiomesterone
TMA
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
TPCP
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
Tranzene®
CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
Trenbolone
CA: CDSA Schedule IV Section 23 Subsection 43 Trenbolone
UK: MDA Part III Class C Section 1(b) Trenbolone
US: CSA Schedule III Section f Subsection 1 Item 64 Trenbolone
Trifluoromethylphenylpiperazine‡
CA: CDSA Schedule III Section 34 Trifluoromethylphenylpiperazine
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine
1-(3-Trifluoromethylphenyl)piperazine
CA: CDSA Schedule III Section 34 Trifluoromethylphenylpiperazine
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine
Trilostane
UK: [not controlled] MDA Part III Class C Section 1(c) Trilostane
Trimeperidine
CA: CDSA Schedule I Section 3 Subsection 21 Trimeperidine
UK: MDA Part I Class A Section 1(a) Trimeperidine
UN: Narcotics Part 1 Section 1 Trimeperidine
US: CSA Schedule I Section b Subsection 55 Trimeperidine
Trimethoxyamphetamine‡
CA: CDSA Schedule I Section 19 Subsection 7 2,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 8 2,4,5-Trimethoxyamphetamine
EU: Substances Substances TMA-2
UK: MDA Part I Class A Section 1(c) 2,4,5-Trimethoxyamphetamine
2,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 7 2,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 8 2,4,5-Trimethoxyamphetamine
EU: Substances Substances TMA-2
UK: MDA Part I Class A Section 1(c) 2,4,5-Trimethoxyamphetamine
3,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
β,2,5-Trimethoxy-4-methylphenethylamine
UK: MDA Part I Class A Section 1(ba) β,2,5-Trimethoxy-4-methylphenethylamine
Tryptamine
UK: MDA Part I Class A Section 1(b) Tryptamine
UR-144
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) UR-144
US: CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
Vinbarbital
CA: CDSA Schedule IV Section 1 Subsection 27 Vinbarbital
Vinylbital
CA: CDSA Schedule IV Section 1 Subsection 28 Vinylbital
UN: Psychotropics Schedule IV Vinylbital
White phosphorous
CA: CDSA Schedule VI Part 1 Subsection 21 White phosphorous
US: CSA Listed Chemicals Section a Subsection 26 White phosphorus
White phosphorus
CA: CDSA Schedule VI Part 1 Subsection 21 White phosphorous
US: CSA Listed Chemicals Section a Subsection 26 White phosphorus
WIN 55,212-2†
UK: MDA Part II Class B Section 1(c) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
XLR11
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
Yellow phosphorus
CA: CDSA Schedule VI Part 1 Subsection 21 White phosphorous
US: CSA Listed Chemicals Section a Subsection 26 White phosphorus
Zanax®
CA: CDSA Schedule IV Section 18 Subsection 1 Alprazolam
UK: MDA Part III Class C Section 1(a) Alprazolam
UN: Psychotropics Schedule IV Alprazolam
US: CSA Schedule IV Section c Subsection 2 Alprazolam
⇒
PubChem: 2118; ChemSpider: 2034; Bluelight: Alprazolam; Drugs Forum: Alprazolam; Erowid: Alprazolam; Wikipedia: Alprazolam
Zilpaterol
UK: MDA Part III Class C Section 1(e) Zilpaterol
Zolpidem
11 March 2016 · 
· Isomer Design
· Isomer Design